<author><surname>Stansfeld</surname> <given-names>CE</given-names></author> <author><surname>Wallis</surname> <given-names>DI</given-names></author> <title>Properties of visceral primary afferent neurons in the nodose ganglion of the rabbit</title> <source>J Neurophysiol</source> <year>1985</year> <volume>54</volume> <fpage>245</fpage> - <lpage>260</lpage>
<author><surname>Undem</surname> <given-names>BJ</given-names></author> <author><surname>Weinreich</surname> <given-names>D</given-names></author> <title>Electrophysiological properties and chemosensitivity of guinea pig nodose ganglion neurons in vitro</title> <source>J Auton Nerv Syst</source> <year>1993</year> <volume>44</volume> <fpage>17</fpage> - <lpage>33</lpage>
<author><surname>Li</surname> <given-names>B-Y</given-names></author> <author><surname>Schild</surname> <given-names>JH</given-names></author> <title>Electrophysiological and pharmacological validation of vagal afferent fiber type of neurons enzymatically isolated from rat nodose ganglia</title> <source>J Neurosci Methods</source> <year>2007</year> <volume>164</volume> <fpage>75</fpage> - <lpage>85</lpage>
<author><surname>Matsumoto</surname> <given-names>S</given-names></author> <author><surname>Okamura</surname> <given-names>H</given-names></author> <author><surname>Suzuki</surname> <given-names>K</given-names></author> <author><surname>Sugai</surname> <given-names>N</given-names></author> <author><surname>Shimizu</surname> <given-names>T</given-names></author> <title>Inhibitory mechanism of CO2 inhalation on slowly adapting pulmonary stretch receptors in the anesthetized rabbit</title> <source>J Pharmacol Exp Ther</source> <year>1998</year> <volume>279</volume> <fpage>402</fpage> - <lpage>409</lpage>
<author><surname>Matsumoto</surname> <given-names>S</given-names></author> <author><surname>Takahashi</surname> <given-names>T</given-names></author> <author><surname>Tanimoto</surname> <given-names>T</given-names></author> <author><surname>Saiki</surname> <given-names>C</given-names></author> <author><surname>Takeda</surname> <given-names>M</given-names></author> <title>Effects of potassium channel blockers on CO2-induced slowly adapting pulmonarstretch receptor inhibition</title> <source>J Pharmacol Exp Ther</source> <year>1999</year> <volume>290</volume> <fpage>974</fpage> - <lpage>979</lpage>
<author><surname>Matsumoto</surname> <given-names>S</given-names></author> <author><surname>Ikeda</surname> <given-names>M</given-names></author> <author><surname>Nishikawa</surname> <given-names>T</given-names></author> <title>Effects of acetazolamide and 4-aminoprydine on the responses of deflationary slowly adapting pulmonary stretch receptors to CO2 inhalation in the rat</title> <source>Life Sci</source> <year>2003</year> <volume>72</volume> <fpage>1757</fpage> - <lpage>1771</lpage>
<author><surname>Matsumoto</surname> <given-names>S</given-names></author> <author><surname>Tanimoto</surname> <given-names>T</given-names></author> <author><surname>Yoshida</surname> <given-names>S</given-names></author> <title>Effects of acetazolamide and 4-aminoprydine on CO2-induced slowly adapting pulmonary stretch receptor inhibition in rats</title> <source>Chem Sences</source> <year>2004</year> <volume>29</volume> <fpage>351</fpage> - <lpage>361</lpage>
<author><surname>Higashi</surname> <given-names>H</given-names></author> <author><surname>Ueda</surname> <given-names>N</given-names></author> <author><surname>Nishi</surname> <given-names>S</given-names></author> <author><surname>Gallagher</surname> <given-names>JP</given-names></author> <author><surname>Shinnnick-Gallagher</surname> <given-names>P</given-names></author> <title>Chemoreceptors for serotonin (5-HT), acetylcholine (Ach), bradykinin (BK), histamine (H) and gamma-aminobutyric acid (GABA) on rabbit visceral afferent neurons</title> <source>Brain Res Bull</source> <year>1992</year> <volume>8</volume> <fpage>23</fpage> - <lpage>32</lpage>
<author><surname>McFarlane</surname> <given-names>S</given-names></author> <author><surname>Cooper</surname> <given-names>E</given-names></author> <title>Kinetics and voltage dependence of A-type currents on neonatal rat sensory neurons</title> <source>J Neurophysiol</source> <year>1991</year> <volume>66</volume> <fpage>1380</fpage> - <lpage>1391</lpage>
<author><surname>Christian</surname> <given-names>EP</given-names></author> <author><surname>Togo</surname> <given-names>J</given-names></author> <author><surname>Naper</surname> <given-names>KE</given-names></author> <title>Guinei pig visceral C-fiber neurons are diverse with respect to the K+ currents involved in action-potential repolarization</title> <source>J Neurophysiol</source> <year>1994</year> <volume>71</volume> <fpage>561</fpage> - <lpage>574</lpage>
<author><surname>Schild</surname> <given-names>JH</given-names></author> <author><surname>Clark</surname> <given-names>JW</given-names></author> <author><surname>Hay</surname> <given-names>M</given-names></author> <author><surname>Mendelowitz</surname> <given-names>D</given-names></author> <author><surname>Andresen</surname> <given-names>MC</given-names></author> <author><surname>Kunze</surname> <given-names>DL</given-names></author> <title>A- and C-type rat nodose sensory neurons: Model interpretations of dynamic discharge characteristics</title> <source>J Neurophysiol</source> <year>1994</year> <volume>71</volume> <fpage>2338</fpage> - <lpage>2358</lpage>
<author><surname>Stansfeld</surname> <given-names>CE</given-names></author> <author><surname>Mersh</surname> <given-names>SJ</given-names></author> <author><surname>Halliwell</surname> <given-names>JV</given-names></author> <author><surname>Brown</surname> <given-names>DA</given-names></author> <title>4-aminoprydine and dendrotoxin induce repetitive firing in rat visceral sensory neurons by blocking a slow inactivating outward current</title> <source>Neurosci Lett</source> <year>1986</year> <volume>64</volume> <fpage>299</fpage> - <lpage>304</lpage>
<author><surname>Storm</surname> <given-names>JF</given-names></author> <title>Intracellular injection of a Ca2+ chelator inhibits spike repolarization in hippocampal neurons</title> <source>Brain Res</source> <year>1987</year> <volume>435</volume> <fpage>387</fpage> - <lpage>392</lpage>
<author><surname>Coetzee</surname> <given-names>WA</given-names></author> <author><surname>Amarillo</surname> <given-names>Y</given-names></author> <author><surname>Chiu</surname> <given-names>J</given-names></author> <title>Molecular diversity of K+ channels</title> <source>Ann NY Acad Sci</source> <year>1999</year> <volume>868</volume> <fpage>233</fpage> - <lpage>285</lpage>
<author><surname>Glazebrook</surname> <given-names>P</given-names></author> <author><surname>Ramirez</surname> <given-names>AN</given-names></author> <author><surname>Schild</surname> <given-names>JH</given-names></author> <author><surname>Shieh</surname> <given-names>CC</given-names></author> <author><surname>Doan</surname> <given-names>T</given-names></author> <author><surname>Wible</surname> <given-names>BA</given-names></author> <author><surname>Kunze</surname> <given-names>DL</given-names></author> <title>Potassium channels Kv1.1, Kv1.2 and Kv1.6 influence excitability of rat visceral sensory neurons</title> <source>J Physiol</source> <year>2002</year> <volume>541</volume> <fpage>467</fpage> - <lpage>482</lpage>
<author><surname>Yoshida</surname> <given-names>S</given-names></author> <author><surname>Matsumoto</surname> <given-names>S</given-names></author> <title>Effects of &#945;-dendrotoxin on K+ currents and action potentials in tetrodotoxin-resistant adult rat trigeminal ganglion neurons</title> <source>J Pharmacol Exp Ther</source> <year>2005</year> <volume>314</volume> <fpage>437</fpage> - <lpage>445</lpage>
<author><surname>McAlexander</surname> <given-names>MA</given-names></author> <author><surname>Undem</surname> <given-names>BJ</given-names></author> <title>Potassium channel blockade induces action potential generation in guinea-pig airway vagal afferent neurons</title> <source>J Auto Nerv Syst</source> <year>2000</year> <volume>78</volume> <fpage>158</fpage> - <lpage>164</lpage>
<author><surname>Harper</surname> <given-names>AA</given-names></author> <title>Similarities between some properties of the soma and sensory receptors of primary afferent neurons</title> <source>Exp Physiol</source> <year>1991</year> <volume>76</volume> <fpage>369</fpage> - <lpage>377</lpage>
<author><surname>Ikeda</surname> <given-names>M</given-names></author> <author><surname>Yoshida</surname> <given-names>S</given-names></author> <author><surname>Kadoi</surname> <given-names>J</given-names></author> <author><surname>Nakano</surname> <given-names>Y</given-names></author> <author><surname>Matsumoto</surname> <given-names>S</given-names></author> <title>The effect of PKC activity on the TTX-R sodium currents from rat nodose ganglion neurons</title> <source>Life Sci</source> <year>2005</year> <volume>78</volume> <fpage>47</fpage> - <lpage>53</lpage>
<author><surname>Matsumoto</surname> <given-names>S</given-names></author> <author><surname>Ikeda</surname> <given-names>M</given-names></author> <author><surname>Yoshida</surname> <given-names>S</given-names></author> <author><surname>Tanimoto</surname> <given-names>T</given-names></author> <author><surname>Takeda</surname> <given-names>M</given-names></author> <author><surname>Nasu</surname> <given-names>M</given-names></author> <title>Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurons</title> <source>Br J Pharmacol</source> <year>2005</year> <volume>145</volume> <fpage>503</fpage> - <lpage>513</lpage>
<author><surname>Matsumoto</surname> <given-names>S</given-names></author> <author><surname>Yoshida</surname> <given-names>S</given-names></author> <author><surname>Ikeda</surname> <given-names>M</given-names></author> <title>Effect of 8-bromo-cAMP on the tetrodotoxin-resistant sodium (Nav 1.8) current in small-diameter nodose ganglion neurons</title> <source>Neuropharmacology</source> <year>2007</year> <volume>52</volume> <fpage>904</fpage> - <lpage>92422</lpage>
<author><surname>Yoshida</surname> <given-names>S</given-names></author> <author><surname>Takahashi</surname> <given-names>M</given-names></author> <author><surname>Kadoi</surname> <given-names>J</given-names></author> <author><surname>Kitagawa</surname> <given-names>J</given-names></author> <author><surname>Saiki</surname> <given-names>C</given-names></author> <author><surname>Takeda</surname> <given-names>M</given-names></author> <author><surname>Matsumoto</surname> <given-names>S</given-names></author> <title>The functional difference between transient and sustained K+ currents on the action potentials in tetrodotoxin-resistant adult rat trigeminal ganglion neurons</title> <source>Brain Res</source> <year>2007</year> <volume>1152</volume> <fpage>64</fpage> - <lpage>74</lpage>
<author><surname>Mo</surname> <given-names>ZL</given-names></author> <author><surname>Davis</surname> <given-names>RL</given-names></author> <title>Endogenous firing patterns of murine spinal ganglion neurons</title> <source>J Neurophysiol</source> <year>1997</year> <volume>77</volume> <fpage>1294</fpage> - <lpage>1305</lpage>
<author><surname>Tsutsui</surname> <given-names>Y</given-names></author> <author><surname>Ikeda</surname> <given-names>M</given-names></author> <author><surname>Takeda</surname> <given-names>M</given-names></author> <author><surname>Matsumoto</surname> <given-names>S</given-names></author> <title>Excitability of small-diameter trigeminal ganglion neurons by 5-HT is mediated by enhancement of the tetrodotoxin-resistant sodium current due to the activation of 5-HT4 receptors and/or by the inhibition of the transient potassium current</title> <source>Neuroscience</source> <year>2008</year> <volume>157</volume> <fpage>683</fpage> - <lpage>696</lpage>
<author><surname>Gold</surname> <given-names>MS</given-names></author> <author><surname>Shuster</surname> <given-names>MJ</given-names></author> <author><surname>Levine</surname> <given-names>JD</given-names></author> <title>Characterization of six voltage-gated K+ currents in adult rat sensory neurons</title> <source>J Neurophysiol</source> <year>1996</year> <volume>75</volume> <fpage>2629</fpage> - <lpage>2646</lpage>
<author><surname>Everill</surname> <given-names>B</given-names></author> <author><surname>Kocsis</surname> <given-names>JD</given-names></author> <title>Reduction in potassium currents in identified cutaneous afferent dorsal root ganglion neurons after axotomy</title> <source>J Neurophysiol</source> <year>1999</year> <volume>82</volume> <fpage>700</fpage> - <lpage>708</lpage>
<author><surname>Takeda</surname> <given-names>M</given-names></author> <author><surname>Tanimoto</surname> <given-names>T</given-names></author> <author><surname>Ikeda</surname> <given-names>M</given-names></author> <author><surname>Kadoi</surname> <given-names>J</given-names></author> <author><surname>Matsumoto</surname> <given-names>S</given-names></author> <title>Activation of GABAB receptor inhibits the excitability of rat small diameter trigeminal root ganglion neurons</title> <source>Neuroscience</source> <year>2004</year> <volume>123</volume> <fpage>491</fpage> - <lpage>505</lpage>
<author><surname>Ikeda</surname> <given-names>M</given-names></author> <author><surname>Matsumoto</surname> <given-names>S</given-names></author> <title>Classification of voltagedependent Ca2+ channels in trigeminal ganglion neurons from neonatal rats</title> <source>Life Sci</source> <year>2003</year> <volume>73</volume> <fpage>1175</fpage> - <lpage>1187</lpage>
<author><surname>Maren</surname> <given-names>TH</given-names></author> <title>Use of inhibitors in physiological studies of carbonic anhydrase</title> <source>Am J Physiol</source> <year>1977</year> <volume>232</volume> <fpage>F291</fpage> - <lpage>297</lpage>
<author><surname>Lee</surname> <given-names>HB</given-names></author> <author><surname>Blaufox</surname> <given-names>MD</given-names></author> <title>Blood volume in the rat</title> <source>J Neucl Med</source> <year>1985</year> <volume>25</volume> <fpage>72</fpage> - <lpage>76</lpage>
<author><surname>Wang</surname> <given-names>EQ</given-names></author> <author><surname>Lee</surname> <given-names>W-I</given-names></author> <author><surname>Brazeau</surname> <given-names>D</given-names></author> <author><surname>Fung</surname> <given-names>H-L</given-names></author> <title>cDNA microarray analysis of vascular gene expression after nitric oxide donor infusion in rats: Implications for nitrate tolerance mechanisms</title> <source>AAPS Pharm Sci</source> <year>2002</year> <volume>4</volume> <fpage>1</fpage> - <lpage>11</lpage>
<author><surname>Puil</surname> <given-names>E</given-names></author> <author><surname>Miura</surname> <given-names>RM</given-names></author> <author><surname>Spigelman</surname> <given-names>I</given-names></author> <title>Consequence of 4-aminoprydine application to trigenal root ganglion neurons</title> <source>J Neurophysiol</source> <year>1989</year> <volume>62</volume> <fpage>810</fpage> - <lpage>820</lpage>
<author><surname>Everill</surname> <given-names>B</given-names></author> <author><surname>Rizzo</surname> <given-names>MA</given-names></author> <author><surname>Kocsis</surname> <given-names>D</given-names></author> <title>Morphologically identified cutaneous afferent DRG neurons express three different potassium currents in varying properties</title> <source>J Neurophysiol</source> <year>1998</year> <volume>79</volume> <fpage>1814</fpage> - <lpage>1824</lpage>
<author><surname>Seifert</surname> <given-names>G</given-names></author> <author><surname>Kuprijanova</surname> <given-names>E</given-names></author> <author><surname>Zhou</surname> <given-names>M</given-names></author> <author><surname>Steinh&#228;user</surname> <given-names>C</given-names></author> <title>Developmental changes in the expression of Shaker- and Shab-related K (+) channels in neurons of the rat trigeminal ganglion</title> <source>Brain Res Mol Brain Res</source> <year>1999</year> <volume>74</volume> <fpage>55</fpage> - <lpage>68</lpage>
<author><surname>Everill</surname> <given-names>B</given-names></author> <author><surname>Rizzo</surname> <given-names>MA</given-names></author> <author><surname>Kocsis</surname> <given-names>JD</given-names></author> <title>Morphologically identified cutaneous afferent DRG neurons express three different potassium currents in varying properties</title> <source>J Neurophysiol</source> <year>1998</year> <volume>79</volume> <fpage>1814</fpage> - <lpage>1824</lpage>
<author><surname>Rasband</surname> <given-names>MN</given-names></author> <author><surname>Park</surname> <given-names>EW</given-names></author> <author><surname>Vanderah</surname> <given-names>TW</given-names></author> <author><surname>Lai</surname> <given-names>J</given-names></author> <author><surname>Porreca</surname> <given-names>F</given-names></author> <author><surname>Trimmer</surname> <given-names>JS</given-names></author> <title>Distinct potassium channels on pain-sensing neurons</title> <source>Proc Natl Acad Sci USA</source> <year>2001</year> <volume>98</volume> <fpage>13373</fpage> - <lpage>13378</lpage>
<author><surname>Winkelman</surname> <given-names>DL</given-names></author> <author><surname>Beck</surname> <given-names>CL</given-names></author> <author><surname>Ypey</surname> <given-names>DL</given-names></author> <author><surname>O&#8217;Leary</surname> <given-names>ME</given-names></author> <title>Inhibition of the A-type K+ channels of dorsal root ganglion neurons by the long-duration anesthetic butamben</title> <source>J Pharmacol Exp Ther</source> <year>2005</year> <volume>314</volume> <fpage>1177</fpage> - <lpage>1186</lpage>
<author><surname>Takeda</surname> <given-names>M</given-names></author> <author><surname>Tanimoto</surname> <given-names>T</given-names></author> <author><surname>Nasu</surname> <given-names>M</given-names></author> <author><surname>Matsumoto</surname> <given-names>S</given-names></author> <title>Tempromandibular joint inflammation decreases the voltage-gated K+ channel subtype 1.4-immunoreactivity of trigeminal ganglion neurons in rats</title> <source>Eur J Pain</source> <year>2008</year> <volume>12</volume> <fpage>189</fpage> - <lpage>195</lpage>
<author><surname>Tanimoto</surname> <given-names>T</given-names></author> <author><surname>Takeda</surname> <given-names>M</given-names></author> <author><surname>Nasu</surname> <given-names>M</given-names></author> <author><surname>Matsumoto</surname> <given-names>S</given-names></author> <title>Immunohistochemical co-expression of carbonic anhydrase II with Kv 1.4 and TRPV1 in the rat small-diameter trigeminal ganglion neurons</title> <source>Brain Res</source> <year>2005</year> <volume>1044</volume> <fpage>262</fpage> - <lpage>265</lpage>
<author><surname>Ho</surname> <given-names>CY</given-names></author> <author><surname>Gu</surname> <given-names>Q</given-names></author> <author><surname>Lin</surname> <given-names>YS</given-names></author> <author><surname>Lee</surname> <given-names>L-Y</given-names></author> <title>Sensitivity of vagal afferent endings to chemical irritants in rat lung</title> <source>Respir Physiol</source> <year>2001</year> <volume>127</volume> <fpage>113</fpage> - <lpage>124</lpage>
<author><surname>Zhang</surname> <given-names>G</given-names></author> <author><surname>Lin</surname> <given-names>R-Y</given-names></author> <author><surname>Wiggers</surname> <given-names>M</given-names></author> <author><surname>Snow</surname> <given-names>DM</given-names></author> <author><surname>Lee</surname> <given-names>L-Y</given-names></author> <title>Altered expression of TRPV1 and sensitivity to capsaicin in pulmonary myelinated afferents following chronic airway inflammation in the rat</title> <source>J Physiol</source> <year>2008</year> <volume>586</volume> <fpage>5771</fpage> - <lpage>5786</lpage>
<author><surname>Kwong</surname> <given-names>K</given-names></author> <author><surname>Carr</surname> <given-names>MJ</given-names></author> <author><surname>Gibbard</surname> <given-names>A</given-names></author> <title>Voltage-gated sodium channels in nociceptive versus non-nociceptive nodode vagal sensory neurons innervating guines pig lungs</title> <source>J Physiol</source> <year>2008</year> <volume>586</volume> <fpage>1321</fpage> - <lpage>1336</lpage>
<author><surname>Ma</surname> <given-names>QP</given-names></author> <title>Expression of capsaicin receptor (VR1) by myelinated primary afferents neurons in the rat</title> <source>Neurosci Lett</source> <year>2002</year> <volume>319</volume> <fpage>87</fpage> - <lpage>90</lpage>
<author><surname>Sun</surname> <given-names>H</given-names></author> <author><surname>Li</surname> <given-names>H-P</given-names></author> <author><surname>Chen</surname> <given-names>S-R</given-names></author> <author><surname>Hittelnan</surname> <given-names>WN</given-names></author> <author><surname>Pan</surname> <given-names>H-L</given-names></author> <title>Sensory of blood pressure induced by transient receptor potential vanilloid 1 receptors on baroreceptors</title> <source>J Pharmacol Exp Ther</source> <year>2009</year> <volume>331</volume> <fpage>851</fpage> - <lpage>859</lpage>
<author><surname>Dalence-Guzman</surname> <given-names>MF</given-names></author> <author><surname>Berglund</surname> <given-names>M</given-names></author> <author><surname>Skogvall</surname> <given-names>S</given-names></author> <author><surname>Sterner</surname> <given-names>O</given-names></author> <title>SAR studies of capsazepinoid bronchodilators. Part1: The importance of the catechol moiety and aspects of the B-ring structure</title> <source>Bioorg Med Chem</source> <year>2008</year> <volume>16</volume> <fpage>2499</fpage> - <lpage>2512</lpage>
<author><surname>Skogvall</surname> <given-names>S</given-names></author> <author><surname>Berglund</surname> <given-names>M</given-names></author> <author><surname>Dalence-Guzm&#225;n</surname> <given-names>MF</given-names></author> <author><surname>Svensson</surname> <given-names>K</given-names></author> <author><surname>J&#246;nsson</surname> <given-names>P</given-names></author> <author><surname>Persson</surname> <given-names>CG</given-names></author> <author><surname>Sterner</surname> <given-names>O</given-names></author> <title>Effects of capsazepine on human small airway responsiveness unravel a novel class of bronchorelaxants</title> <source>Pulm Pharmacol Ther</source> <year>2007</year> <volume>20</volume> <fpage>273</fpage> - <lpage>280</lpage>
<author><surname>Hasannejad</surname> <given-names>H</given-names></author> <author><surname>Takeda</surname> <given-names>M</given-names></author> <author><surname>Taki</surname> <given-names>K</given-names></author> <title>Interactions of human organic anion transporters with diuretics</title> <source>J Pharmacol Exp Ther</source> <year>2004</year> <volume>308</volume> <fpage>1021</fpage> - <lpage>1029</lpage>
<author><surname>Faraci</surname> <given-names>FM</given-names></author> <author><surname>Mayhan</surname> <given-names>WG</given-names></author> <author><surname>Heistad</surname> <given-names>DD</given-names></author> <title>Vascular effects of acetazolamide on the choroid plexus</title> <source>J Pharmacol Exp Ther</source> <year>1990</year> <volume>254</volume> <fpage>23</fpage> - <lpage>27</lpage>
<author><surname>Wang</surname> <given-names>Q</given-names></author> <author><surname>Paulson</surname> <given-names>OB</given-names></author> <author><surname>Lassen</surname> <given-names>NA</given-names></author> <title>Indomethacin abolishes cerebral blood flow increase in response to acetazolamide-induced extracellular acidosis: A mechanism for its effect on hypercapnia</title>? <source>J Cereb Blood Flow Metab</source> <year>1993</year> <volume>13</volume> <fpage>724</fpage> - <lpage>727</lpage>
<author><surname>Pickkers</surname> <given-names>P</given-names></author> <author><surname>Hughes</surname> <given-names>AD</given-names></author> <author><surname>Russel</surname> <given-names>FG</given-names></author> <author><surname>Thien</surname> <given-names>T</given-names></author> <author><surname>Smits</surname> <given-names>T</given-names></author> <title>In vivo evidence for K (Ca) channel opening properties of acetazolamide in the human vasculature</title> <source>Br J Pharmacol</source> <year>2001</year> <volume>132</volume> <fpage>443</fpage> - <lpage>450</lpage>
<author><surname>Tricarico</surname> <given-names>D</given-names></author> <author><surname>Lovaglio</surname> <given-names>S</given-names></author> <author><surname>Mele</surname> <given-names>A</given-names></author> <author><surname>Rotondo</surname> <given-names>G</given-names></author> <author><surname>Mancinelli</surname> <given-names>E</given-names></author> <author><surname>Meola</surname> <given-names>G</given-names></author> <author><surname>Camerino</surname> <given-names>DC</given-names></author> <title>Acetazolamide prevents vacuolar myopathy in skeletal muscle of K+-depleted rats</title> <source>Br J Pharmacol</source> <year>2008</year> <volume>154</volume> <fpage>183</fpage> - <lpage>190</lpage>
<author><surname>Swenson</surname> <given-names>ER</given-names></author> <title>Carbonic anhydrase inhibitors and ventilation: A complex interplay of stimulation and suppression</title> <source>Eur Respir J</source> <year>1998</year> <volume>12</volume> <fpage>1242</fpage> - <lpage>1247</lpage>
<author><surname>Teppema</surname> <given-names>LJ</given-names></author> <author><surname>Dahan</surname> <given-names>A</given-names></author> <title>Low-dose acetazolamide reduces the hypoxic ventilatory response in the anesthetized cat</title> <source>Respir Physiol Neurobiol</source> <year>2004</year> <volume>140</volume> <fpage>43</fpage> - <lpage>51</lpage>
<author><surname>Lehmann-Horn</surname> <given-names>F</given-names></author> <author><surname>R&#252;del</surname> <given-names>R</given-names></author> <author><surname>Jurkat-Rott</surname> <given-names>K</given-names></author> <author><surname>Engel</surname> <given-names>AG</given-names></author>, <author><surname>Franzini-Armstrong</surname> <given-names>C</given-names></author> <title>Altered excitability of the cell membrane</title>: <source>Myology</source> <year>2004</year> <volume>46</volume> <issue>3rd ed</issue> <other>USA</other> <publisher>McGraw-Hill Press</publisher> <fpage>1257</fpage> - <lpage>1300</lpage>
<author><surname>Clare</surname> <given-names>BW</given-names></author> <author><surname>Supuran</surname> <given-names>CT</given-names></author> <title>A perspective on quantitative structure-activity relationships and carbonic anhydrase inhibitors</title> <source>Expert Opin Drug Metab Toxicol</source> <year>2006</year> <volume>2</volume> <fpage>113</fpage> - <lpage>137</lpage>
<author><surname>Venance</surname> <given-names>SL</given-names></author> <author><surname>Cannon</surname> <given-names>SC</given-names></author> <author><surname>Fialho</surname> <given-names>D</given-names></author> <title>The primary periodic paralyses: Diagnosis, pathogenesis and treatment</title> <source>Brain</source> <year>2006</year> <volume>129</volume> <fpage>8</fpage> - <lpage>17</lpage>
<author><surname>Ades</surname> <given-names>P</given-names></author> <author><surname>Savage</surname> <given-names>PD</given-names></author> <author><surname>Tischler</surname> <given-names>MD</given-names></author> <author><surname>Poehlman</surname> <given-names>ET</given-names></author> <author><surname>Dee</surname> <given-names>J</given-names></author> <author><surname>Niggel</surname> <given-names>J</given-names></author> <title>Determinants of disability in older coronary patients</title> <source>American Heart Journal</source> <year>2002</year> <volume>143</volume> <fpage>151</fpage> - <lpage>156</lpage>
American Heart Association <source>Cardiovascular disease statistics</source> <year>2006</year> <publisher>Retrieved from</publisher>
<author><surname>Ayabe</surname> <given-names>M</given-names></author> <author><surname>Brubaker</surname> <given-names>PH</given-names></author> <author><surname>Mori</surname> <given-names>Y</given-names></author> <author><surname>Kumahara</surname> <given-names>H</given-names></author> <author><surname>Kiyonaga</surname> <given-names>A</given-names></author> <author><surname>Tanaka</surname> <given-names>H</given-names></author> <author><surname>Aoki</surname> <given-names>J</given-names></author> <title>Self-monitoring moderate-vigorous physical activity versus steps/day is more effective in chronic disease exercise programs</title> <source>Journal of Cadiopulmonary Rehabiliation and Prevention</source> <year>2009</year> <volume>39</volume> <fpage>12</fpage> - <lpage>18</lpage>
<author><surname>Bandura</surname> <given-names>A</given-names></author> <source>Self-efficacy: The exercise of control</source> <year>1997</year> <other>New York</other> <publisher>W.H. Freeman and Co</publisher>
<author><surname>Bernier</surname> <given-names>M</given-names></author> <author><surname>Avard</surname> <given-names>J</given-names></author> <title>Self-efficacy, outcome, and attrition in a weight-reduction program</title> <source>Cognitive Therapy and Research</source> <year>1986</year> <volume>10</volume> <fpage>319</fpage> - <lpage>338</lpage>
<author><surname>Borg</surname> <given-names>G</given-names></author> <title>Perceived exertion and pain scales</title> <year>1998</year> <other>Champaign, IL</other> <publisher>Human Kinetics</publisher>
<author><surname>Chao</surname> <given-names>D</given-names></author> <author><surname>Farmer</surname> <given-names>DF</given-names></author> <author><surname>Sevick</surname> <given-names>MA</given-names></author> <author><surname>Espeland</surname> <given-names>MA</given-names></author> <author><surname>Vitolins</surname> <given-names>M</given-names></author> <author><surname>Naughton</surname> <given-names>MJ</given-names></author> <title>The value of session attendance in a weight-loss intervention</title> <source>American Journal of Health Behavior</source> <year>2010</year> <volume>24</volume> <fpage>413</fpage> - <lpage>421</lpage>
<author><surname>Clark</surname> <given-names>BA</given-names></author> <author><surname>Wade</surname> <given-names>MG</given-names></author> <author><surname>Massey</surname> <given-names>BH</given-names></author> <author><surname>Van Dyke</surname> <given-names>R</given-names></author> <title>Response of institutionalized geriatric mental patients to a twelve-week program of regular physical activity</title> <source>Journal of Gerontology: Medical Sciences</source> <year>1975</year> <volume>30</volume> <fpage>565</fpage> - <lpage>573</lpage>
<author><surname>Clark</surname> <given-names>MM</given-names></author> <author><surname>Abrams</surname> <given-names>DB</given-names></author> <author><surname>Niaura</surname> <given-names>RS</given-names></author> <author><surname>Eaton</surname> <given-names>CA</given-names></author> <author><surname>Rossi</surname> <given-names>JS</given-names></author> <title>Self-efficacy in weight management</title> <source>Journal of Consulting and Clinical Psychology</source> <year>1991</year> <volume>59</volume> <fpage>739</fpage> - <lpage>744</lpage>
<author><surname>Dansinger</surname> <given-names>ML</given-names></author> <author><surname>Gleason</surname> <given-names>JA</given-names></author> <author><surname>Griffith</surname> <given-names>JL</given-names></author> <author><surname>Selker</surname> <given-names>HP</given-names></author> <author><surname>Schaefer</surname> <given-names>EJ</given-names></author> <title>Comparison of the Atkins, Ornish, Weight watchers, and Zone diets for weight loss and heart disease risk reduction</title> <source>Journal of the American Medical Association</source> <year>2005</year> <volume>293</volume> <fpage>43</fpage> - <lpage>53</lpage>
<title>Expert Panel on Detection Executive summary of the third report of the national cholesterol education program</title> <source>Journal of the American Medical Association</source> <year>2001</year> <volume>285</volume> <fpage>2486</fpage> - <lpage>2497</lpage>
<author><surname>Fontaine</surname> <given-names>KR</given-names></author> <author><surname>Cheskin</surname> <given-names>LJ</given-names></author> <title>Self-efficacy, attendance, and weight loss in obesity treatment</title> <source>Addictive Behaviors</source> <year>1997</year> <volume>22</volume> <fpage>567</fpage> - <lpage>570</lpage>
<author><surname>Jeffery</surname> <given-names>RW</given-names></author> <author><surname>Bjornsonbenson</surname> <given-names>WM</given-names></author> <author><surname>Rosenthal</surname> <given-names>BS</given-names></author> <author><surname>Lindquist</surname> <given-names>RA</given-names></author> <author><surname>Kurth</surname> <given-names>CL</given-names></author> <author><surname>Johnson</surname> <given-names>SL</given-names></author> <title>Correlates of weight-loss and its maintenance over 2 years of follow-up among middle-aged men</title> <source>Preventive Medicine</source> <year>1984</year> <volume>13</volume> <fpage>155</fpage> - <lpage>168</lpage>
<author><surname>Linde</surname> <given-names>JA</given-names></author> <author><surname>Rothman</surname> <given-names>AJ</given-names></author> <author><surname>Baldwin</surname> <given-names>AS</given-names></author> <author><surname>Jeffery</surname> <given-names>RW</given-names></author> <title>The impact of self-efficacy on behavior change and weight change among overweight participants in a weight loss trial</title> <source>Health Psychology</source> <year>2006</year> <volume>25</volume> <fpage>282</fpage> - <lpage>291</lpage>
<author><surname>MacKinnon</surname> <given-names>DP</given-names></author> <author><surname>Fairchild</surname> <given-names>AJ</given-names></author> <author><surname>Fritz</surname> <given-names>MS</given-names></author> <title>Mediation analysis</title> <source>Annual Review of Psychology</source> <year>2007</year> <volume>58</volume> <fpage>593</fpage> - <lpage>614</lpage>
<author><surname>MacKinnon</surname> <given-names>DP</given-names></author> <author><surname>Fritz</surname> <given-names>MS</given-names></author> <author><surname>Williams</surname> <given-names>J</given-names></author> <author><surname>Lockwood</surname> <given-names>CH</given-names></author> <title>Distribution of the product confidence limits for the indirect effect</title>: <source>Program PRODCLIN Behavior Research Methods</source> <year>2007</year> <volume>39</volume> <fpage>384</fpage> - <lpage>389</lpage>
<author><surname>Marsh</surname> <given-names>AP</given-names></author> <author><surname>Vance</surname> <given-names>RM</given-names></author> <author><surname>Frederick</surname> <given-names>TL</given-names></author> <author><surname>Hesselmann</surname> <given-names>SA</given-names></author> <author><surname>Rejeski</surname> <given-names>WJ</given-names></author> <title>Objective assessment of activity in older adults at risk for mobility disability</title> <source>Medicine and Science in Sports and Exercise</source> <year>2007</year> <volume>39</volume> <fpage>1020</fpage> - <lpage>1026</lpage>
<author><surname>Perri</surname> <given-names>MG</given-names></author> <author><surname>Nezu</surname> <given-names>AM</given-names></author> <author><surname>McKelvey</surname> <given-names>WF</given-names></author> <author><surname>Shermer</surname> <given-names>RL</given-names></author> <author><surname>Renjilian</surname> <given-names>DA</given-names></author> <author><surname>Viegener</surname> <given-names>BJ</given-names></author> <title>Relapse prevention training and problem-solving therapy in the long-term management of obesity</title> <source>Journal of Consulting and Clinical Psychology</source> <year>2001</year> <volume>69</volume> <fpage>722</fpage> - <lpage>726</lpage>
<author><surname>Rejeski</surname> <given-names>WJ</given-names></author> <author><surname>Blumenthal</surname> <given-names>TD</given-names></author> <author><surname>Miller</surname> <given-names>GD</given-names></author> <author><surname>Lobe</surname> <given-names>M</given-names></author> <author><surname>Davis</surname> <given-names>C</given-names></author> <author><surname>Brown</surname> <given-names>L</given-names></author> <title>State craving, food availability, and reactivity to preferred snack foods</title> <source>Appetite</source> <year>2010</year> <volume>54</volume> <fpage>77</fpage> - <lpage>83</lpage>
<author><surname>Rejeski</surname> <given-names>WJ</given-names></author> <author><surname>Brawley</surname> <given-names>LR</given-names></author> <author><surname>Ambrosius</surname> <given-names>W</given-names></author> <author><surname>Brubaker</surname> <given-names>PH</given-names></author> <author><surname>Focht</surname> <given-names>BC</given-names></author> <author><surname>Foy</surname> <given-names>CG</given-names></author> <author><surname>Fox</surname> <given-names>LD</given-names></author> <title>Older adults with chronic disease: The benefits of group mediated counseling in the promotion of physically active lifestyles</title> <source>Health Psychology</source> <year>2003</year> <volume>22</volume> <fpage>414</fpage> - <lpage>423</lpage>
<author><surname>Rejeski</surname> <given-names>WJ</given-names></author> <author><surname>Marsh</surname> <given-names>AP</given-names></author> <author><surname>Chmelo</surname> <given-names>E</given-names></author> <author><surname>Rejeski</surname> <given-names>JJ</given-names></author> <title>Obesity, intentional weight loss and physical disability in older adults</title> <source>Obesity Reviews</source> <year>2010</year> <volume>11</volume> <fpage>671</fpage> - <lpage>685</lpage>
<author><surname>Richman</surname> <given-names>RM</given-names></author> <author><surname>Loughnan</surname> <given-names>GT</given-names></author> <author><surname>Droulers</surname> <given-names>AM</given-names></author> <author><surname>Steinbeck</surname> <given-names>KS</given-names></author> <author><surname>Caterson</surname> <given-names>ID</given-names></author> <title>Self-efficacy in relation to eating behaviour among obese and non-obese women</title> <source>International Journal of Obesity</source> <year>2001</year> <volume>25</volume> <fpage>907</fpage> - <lpage>913</lpage>
SAS <title>Insitute, Raleigh, NC.User note 23600: How can I compute the eta2, partial eta2, or emega2 statistics? Retrieved</title> from:
<author><surname>Savage</surname> <given-names>PD</given-names></author> <author><surname>Ades</surname> <given-names>PA</given-names></author> <title>The obesity epidemic in the United States: Role of cardiac rehabilitation</title> <source>Coronary Artery Disease</source> <year>2006</year> <volume>17</volume> <fpage>227</fpage> - <lpage>231</lpage>
<author><surname>Schwarzer</surname> <given-names>R</given-names></author> <title>Optimism, goals, and threats: How to conceptualize self-regulatory processes in the adoption and maintenance of health behaviors</title> <source>Psychology and Health</source> <year>1998</year> <volume>13</volume> <fpage>759</fpage> - <lpage>767</lpage>
<author><surname>Schwarzer</surname> <given-names>R</given-names></author> <author><surname>Renner</surname> <given-names>B</given-names></author> <title>Social-cognitive predictors of health behavior: Action self-efficacy and coping self-efficacy</title> <source>Health Psychology</source> <year>2000</year> <volume>19</volume> <fpage>487</fpage> - <lpage>495</lpage>
<author><surname>Stotland</surname> <given-names>S</given-names></author> <author><surname>Zuroff</surname> <given-names>DC</given-names></author> <title>Relations between multiple measures of dieting self-efficacy and weight change in a behavioral weight control program</title> <source>Behavior Therapy</source> <year>1991</year> <volume>22</volume> <fpage>47</fpage> - <lpage>59</lpage>
<author><surname>Stotland</surname> <given-names>S</given-names></author> <author><surname>Zuroff</surname> <given-names>DC</given-names></author> <author><surname>Roy</surname> <given-names>M</given-names></author> <title>Situational dieting self-efficacy and short-term regulation of eating</title> <source>Appetite</source> <year>1991</year> <volume>17</volume> <fpage>81</fpage> - <lpage>90</lpage>
<author><surname>Wadden</surname> <given-names>TA</given-names></author> <author><surname>Osei</surname> <given-names>S</given-names></author> <author><surname>Wadden</surname> <given-names>TA</given-names></author>, <author><surname>Stunkard</surname> <given-names>AJ</given-names></author> <title>The treatment of obesity: An overview</title> <source>Handbook of obesity treatment</source> <year>2002</year> <other>New York</other> <publisher>The Guilford Press</publisher> <fpage>229</fpage> - <lpage>248</lpage>
<author><surname>Warziski</surname> <given-names>MT</given-names></author> <author><surname>Sereika</surname> <given-names>SM</given-names></author> <author><surname>Styn</surname> <given-names>MA</given-names></author> <author><surname>Music</surname> <given-names>E</given-names></author> <author><surname>Burke</surname> <given-names>LE</given-names></author> <title>Changes in self-efficacy and dietary adherence: The impact on weight loss in the PREFER study</title> <source>Journal of Behavioral Medicine</source> <year>2008</year> <volume>31</volume> <fpage>81</fpage> - <lpage>92</lpage>
<author><surname>Wenger</surname> <given-names>NK</given-names></author> <author><surname>Froelicher</surname> <given-names>ES</given-names></author> <author><surname>Smith</surname> <given-names>LK</given-names></author> <author><surname>Ades</surname> <given-names>PA</given-names></author> <author><surname>Berra</surname> <given-names>K</given-names></author> <author><surname>Blumenthal</surname> <given-names>JA</given-names></author> <source>Cardiac rehabilitation</source> <year>1995</year> <other>Washington, DC</other> <author><given-names>U.S</given-names></author>. <source>Department of Health</source> <publisher>and Human Services</publisher>
<author><surname>Nordin</surname> <given-names>AJ</given-names></author> <title>Primary carcinoma of the fallopian tube: a 20-year literature review</title> <source>Obstet Gynecol Surv</source> <year>1994</year> <volume>49</volume> <fpage>349</fpage> - <lpage>361</lpage>
<author><surname>Tr&#233;tarre</surname> <given-names>B</given-names></author> <author><surname>Remontet</surname> <given-names>L</given-names></author> <author><surname>Menegoz</surname> <given-names>F</given-names></author> <author><surname>Mace-Lesec"h</surname> <given-names>J</given-names></author> <author><surname>Grosclaude</surname> <given-names>P</given-names></author> <author><surname>Buemi</surname> <given-names>A</given-names></author> <title>Ovarian cancer: incidence and mortality in France</title> <source>J Gynecol Obstet Biol Reprod (Paris)</source> <year>2005</year> <volume>34</volume> <fpage>154</fpage> - <lpage>161</lpage>
<author><surname>Baekelandt</surname> <given-names>M</given-names></author> <author><surname>Jorunn Nesbakken</surname> <given-names>A</given-names></author> <author><surname>Kristensen</surname> <given-names>GB</given-names></author> <author><surname>Trope</surname> <given-names>CG</given-names></author> <author><surname>Abeler</surname> <given-names>VM</given-names></author> <title>Carcinoma of the fallopian tube</title> <source>Cancer</source> <year>2000</year> <volume>89</volume> <fpage>2076</fpage> - <lpage>2084</lpage>
<author><surname>Moore</surname> <given-names>KN</given-names></author> <author><surname>Moxley</surname> <given-names>KM</given-names></author> <author><surname>Fader</surname> <given-names>AN</given-names></author> <author><surname>Axtell</surname> <given-names>AE</given-names></author> <author><surname>Rocconi</surname> <given-names>RP</given-names></author> <author><surname>Abaid</surname> <given-names>LN</given-names></author> <title>Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary</title> <source>Gynecol Oncol</source> <year>2007</year> <volume>107</volume> <fpage>398</fpage> - <lpage>403</lpage>
<author><surname>Wethington</surname> <given-names>SL</given-names></author> <author><surname>Herzog</surname> <given-names>TJ</given-names></author> <author><surname>Seshan</surname> <given-names>VE</given-names></author> <author><surname>Bansal</surname> <given-names>N</given-names></author> <author><surname>Schiff</surname> <given-names>PB</given-names></author> <author><surname>Burke</surname> <given-names>WM</given-names></author> <title>Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer</title> <source>Cancer</source> <year>2008</year> <volume>113</volume> <fpage>3298</fpage> - <lpage>3306</lpage>
<author><surname>Deffieux</surname> <given-names>X</given-names></author> <author><surname>Morice</surname> <given-names>P</given-names></author> <author><surname>Thoury</surname> <given-names>A</given-names></author> <author><surname>Camatte</surname> <given-names>S</given-names></author> <author><surname>Duvillard</surname> <given-names>P</given-names></author> <author><surname>Castaigne</surname> <given-names>D</given-names></author> <title>Pelvic and para-aortic lymphatic involvement in tubal carcinoma: topography and surgical implications</title> <source>Gynecol Obstet Fertil</source> <year>2005</year> <volume>33</volume> <fpage>23</fpage> - <lpage>28</lpage>
<author><surname>Tavassoli</surname> <given-names>FA</given-names></author> <author><surname>Devilee</surname> <given-names>P</given-names></author> <title>Pathology and genetics of tumours of the breast and female genital organs (IARC WHO classification of tumours</title>, <source>No 4)</source> <year>2003</year> <other>Lyon</other> <publisher>IARC Press</publisher>
<author><surname>Pectasides</surname> <given-names>D</given-names></author> <author><surname>Pectasides</surname> <given-names>E</given-names></author> <author><surname>Economopoulos</surname> <given-names>T</given-names></author> <title>Fallopian tube carcinoma: a review</title> <source>Oncologist</source> <year>2006</year> <volume>11</volume> <fpage>902</fpage> - <lpage>912</lpage>
<author><surname>Tamimi</surname> <given-names>HK</given-names></author> <author><surname>Figge</surname> <given-names>DC</given-names></author> <title>Adenocarcinoma of the uterine tube: potential for lymph node metastases</title> <source>Am J Obstet Gynecol</source> <year>1981</year> <volume>141</volume> <fpage>132</fpage> - <lpage>137</lpage>
<author><surname>Cormio</surname> <given-names>G</given-names></author> <author><surname>Lissoni</surname> <given-names>A</given-names></author> <author><surname>Maneo</surname> <given-names>A</given-names></author> <author><surname>Marzola</surname> <given-names>M</given-names></author> <author><surname>Gabriele</surname> <given-names>A</given-names></author> <author><surname>Mangioni</surname> <given-names>C</given-names></author> <title>Lymph node involvement in primary carcinoma of the fallopian tube</title> <source>Int J Gynecol Cancer</source> <year>1996</year> <volume>6</volume> <fpage>405</fpage> - <lpage>409</lpage>
<author><surname>di Re</surname> <given-names>E</given-names></author> <author><surname>Grosso</surname> <given-names>G</given-names></author> <author><surname>Raspagliesi</surname> <given-names>F</given-names></author> <author><surname>Baiocchi</surname> <given-names>G</given-names></author> <title>Fallopian tube cancer: incidence and role of lymphatic spread</title> <source>Gynecol Oncol</source> <year>1996</year> <volume>62</volume> <fpage>199</fpage> - <lpage>202</lpage>
<author><surname>Leblanc</surname> <given-names>E</given-names></author> <author><surname>Querleu</surname> <given-names>D</given-names></author> <author><surname>Narducci</surname> <given-names>F</given-names></author> <author><surname>Occelli</surname> <given-names>B</given-names></author> <author><surname>Papageorgiou</surname> <given-names>T</given-names></author> <author><surname>Sonoda</surname> <given-names>Y</given-names></author> <title>Laparoscopic restaging of early stage invasive adnexal tumors: a 10-year experience</title> <source>Gynecol Oncol</source> <year>2004</year> <volume>94</volume> <fpage>624</fpage> - <lpage>629</lpage>
<author><surname>Maxson</surname> <given-names>WZ</given-names></author> <author><surname>Stehman</surname> <given-names>FB</given-names></author> <author><surname>Ulbright</surname> <given-names>TM</given-names></author> <author><surname>Sutton</surname> <given-names>GP</given-names></author> <author><surname>Ehrlich</surname> <given-names>CE</given-names></author> <title>Primary carcinoma of the fallopian tube: evidence for activity of cisplatin combination therapy</title> <source>Gynecol Oncol</source> <year>1987</year> <volume>26</volume> <fpage>305</fpage> - <lpage>313</lpage>
<author><surname>Muntz</surname> <given-names>HG</given-names></author> <author><surname>Tarraza</surname> <given-names>HM</given-names></author> <author><surname>Goff</surname> <given-names>BA</given-names></author> <author><surname>Granai</surname> <given-names>GO</given-names></author> <author><surname>Rice</surname> <given-names>LW</given-names></author> <author><surname>Nikrui</surname> <given-names>N</given-names></author> <title>Combination chemotherapy in advanced adenocarcinoma of the fallopian tube</title> <source>Gynecol Oncol</source> <year>1991</year> <volume>40</volume> <fpage>268</fpage> - <lpage>273</lpage>
<author><surname>Morris</surname> <given-names>M</given-names></author> <author><surname>Gershenson</surname> <given-names>DM</given-names></author> <author><surname>Burke</surname> <given-names>TW</given-names></author> <author><surname>Kavanagh</surname> <given-names>JJ</given-names></author> <author><surname>Silva</surname> <given-names>EG</given-names></author> <author><surname>Wharton</surname> <given-names>JT</given-names></author> <title>Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide</title> <source>Obstet Gynecol</source> <year>1990</year> <volume>76</volume> <fpage>1020</fpage> - <lpage>1024</lpage>
<author><surname>Barakat</surname> <given-names>RR</given-names></author> <author><surname>Rubin</surname> <given-names>SC</given-names></author> <author><surname>Saigo</surname> <given-names>PE</given-names></author> <author><surname>Lewis</surname> <given-names>JL</given-names></author> <author><surname>Jr Jones</surname> <given-names>WB</given-names></author> <author><surname>Curtin</surname> <given-names>JP</given-names></author> <title>Second-look laparotomy in carcinoma of the fallopian tube</title> <source>Obstet Gynecol</source> <year>1993</year> <volume>82</volume> <fpage>748</fpage> - <lpage>751</lpage>
<author><surname>Peters</surname> <given-names>WA</given-names></author> <author><surname>3rd Andersen</surname> <given-names>WA</given-names></author> <author><surname>Hopkins</surname> <given-names>MP</given-names></author> <title>Results of chemotherapy in advanced carcinoma of the fallopian tube</title> <source>Cancer</source> <year>1989</year> <volume>63</volume> <fpage>836</fpage> - <lpage>838</lpage>
<author><surname>Pectasides</surname> <given-names>D</given-names></author> <author><surname>Pectasides</surname> <given-names>E</given-names></author> <author><surname>Papaxoinis</surname> <given-names>G</given-names></author> <author><surname>Andreadis</surname> <given-names>C</given-names></author> <author><surname>Papatsibas</surname> <given-names>G</given-names></author> <author><surname>Fountzilas</surname> <given-names>G</given-names></author> <title>Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients</title> <source>Gynecol Oncol</source> <year>2009</year> <volume>115</volume> <fpage>97</fpage> - <lpage>101</lpage>
<author><surname>Roh</surname> <given-names>MH</given-names></author> <author><surname>Kindelberger</surname> <given-names>D</given-names></author> <author><surname>Crum</surname> <given-names>CP</given-names></author> <title>Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin</title>? <source>Am J Surg Pathol</source> <year>2009</year> <volume>33</volume> <fpage>376</fpage> - <lpage>383</lpage>
<author><surname>Jarboe</surname> <given-names>EA</given-names></author> <author><surname>Folkins</surname> <given-names>AK</given-names></author> <author><surname>Drapkin</surname> <given-names>R</given-names></author> <author><surname>Ince</surname> <given-names>TA</given-names></author> <author><surname>Agoston</surname> <given-names>ES</given-names></author> <author><surname>Crum</surname> <given-names>CP</given-names></author> <title>Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective</title> <source>Histopathology</source> <year>2008</year> <volume>53</volume> <fpage>127</fpage> - <lpage>138</lpage>
<author><surname>Kindelberger</surname> <given-names>DW</given-names></author> <author><surname>Lee</surname> <given-names>Y</given-names></author> <author><surname>Miron</surname> <given-names>A</given-names></author> <author><surname>Hirsch</surname> <given-names>MS</given-names></author> <author><surname>Feltmate</surname> <given-names>C</given-names></author> <author><surname>Medeiros</surname> <given-names>F</given-names></author> <title>Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship</title> <source>Am J Surg Pathol</source> <year>2007</year> <volume>31</volume> <fpage>161</fpage> - <lpage>169</lpage>
<author><surname>Carlson</surname> <given-names>JW</given-names></author> <author><surname>Miron</surname> <given-names>A</given-names></author> <author><surname>Jarboe</surname> <given-names>EA</given-names></author> <author><surname>Parast</surname> <given-names>MM</given-names></author> <author><surname>Hirsch</surname> <given-names>MS</given-names></author> <author><surname>Lee</surname> <given-names>Y</given-names></author> <title>Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention</title> <source>J Clin Oncol</source> <year>2008</year> <volume>26</volume> <fpage>4160</fpage> - <lpage>4165</lpage>
<author><surname>Crum</surname> <given-names>CP</given-names></author> <author><surname>Drapkin</surname> <given-names>R</given-names></author> <author><surname>Kindelberger</surname> <given-names>D</given-names></author> <author><surname>Medeiros</surname> <given-names>F</given-names></author> <author><surname>Miron</surname> <given-names>A</given-names></author> <author><surname>Lee</surname> <given-names>Y</given-names></author> <title>Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer</title> <source>Clin Med Res</source> <year>2007</year> <volume>5</volume> <fpage>35</fpage> - <lpage>44</lpage>
<author><surname>Semmel</surname> <given-names>DR</given-names></author> <author><surname>Folkins</surname> <given-names>AK</given-names></author> <author><surname>Hirsch</surname> <given-names>MS</given-names></author> <author><surname>Nucci</surname> <given-names>MR</given-names></author> <author><surname>Crum</surname> <given-names>CP</given-names></author> <title>Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria</title> <source>Mod Pathol</source> <year>2009</year> <volume>22</volume> <fpage>985</fpage> - <lpage>988</lpage>
<author><surname>Deligdisch</surname> <given-names>L</given-names></author> <author><surname>Penault-Llorca</surname> <given-names>F</given-names></author> <author><surname>Schlosshauer</surname> <given-names>P</given-names></author> <author><surname>Altchek</surname> <given-names>A</given-names></author> <author><surname>Peiretti</surname> <given-names>M</given-names></author> <author><surname>Nezhat</surname> <given-names>F</given-names></author> <author><surname>Stage</surname> <given-names>I</given-names></author> <title>ovarian carcinoma: different clinical pathologic patterns</title> <source>Fertil Steril</source> <year>2007</year> <volume>88</volume> <fpage>906</fpage> - <lpage>910</lpage>
<author><surname>Mettlin</surname> <given-names>CJ</given-names></author> <author><surname>Murphy</surname> <given-names>GP</given-names></author> <author><surname>Rosenthal</surname> <given-names>DS</given-names></author> <title>The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer</title> <source>Society Cancer</source> <year>1998</year> <volume>83</volume> <fpage>1679</fpage> - <lpage>84</lpage>
<author><surname>Mettlin</surname> <given-names>CJ</given-names></author> <author><surname>Murphy</surname> <given-names>GP</given-names></author> <author><surname>McDonald</surname> <given-names>CJ</given-names></author> <title>The National Cancer Data Base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the</title> <source>U.S Cancer</source> <year>1999</year> <volume>86</volume> <fpage>1877</fpage> - <lpage>82</lpage>
<author><surname>Shipley</surname> <given-names>WU</given-names></author> <author><surname>Thames</surname> <given-names>HD</given-names></author> <author><surname>Sandler</surname> <given-names>HM</given-names></author> <title>Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis</title> <source>JAMA</source> <year>1999</year> <volume>281</volume> <fpage>1598</fpage> - <lpage>604</lpage>
<author><surname>D&#8217;Amico</surname> <given-names>AV</given-names></author> <author><surname>Chen</surname> <given-names>MH</given-names></author> <author><surname>Renshaw</surname> <given-names>AA</given-names></author> <author><surname>Loffredo</surname> <given-names>B</given-names></author> <author><surname>Kantoff</surname> <given-names>PW</given-names></author> <title>Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy</title> <source>J Clin Oncol</source> <year>2008</year> <volume>26</volume> <fpage>2979</fpage> - <lpage>83</lpage>
<author><surname>Suzuki</surname> <given-names>N</given-names></author> <author><surname>Shimbo</surname> <given-names>M</given-names></author> <author><surname>Amiya</surname> <given-names>Y</given-names></author> <title>Outcome of patients with localized prostate cancer treated by radiotherapy after confirming the absence of lymph node invasion</title> <source>Jpn J Clin Oncol</source> <year>2010</year> <volume>40</volume> <fpage>652</fpage> - <lpage>7</lpage>
<author><surname>Touma</surname> <given-names>NJ</given-names></author> <author><surname>Izawa</surname> <given-names>JI</given-names></author> <author><surname>Chin</surname> <given-names>JL</given-names></author> <title>Current status of local salvage therapies following radiation failure for prostate cancer</title> <source>J Urol</source> <year>2005</year> <volume>173</volume> <fpage>373</fpage> - <lpage>9</lpage>
<author><surname>Zietman</surname> <given-names>AL</given-names></author> <author><surname>Bae</surname> <given-names>K</given-names></author> <author><surname>Slater</surname> <given-names>JD</given-names></author> <title>Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/American College of radiology 95&#8211;09</title> <source>J Clin Oncol</source> <year>2010</year> <volume>28</volume> <fpage>1106</fpage> - <lpage>11</lpage>
<author><surname>Crook</surname> <given-names>JM</given-names></author> <author><surname>Perry</surname> <given-names>GA</given-names></author> <author><surname>Robertson</surname> <given-names>S</given-names></author> <author><surname>Esche</surname> <given-names>BA</given-names></author> <title>Routine biopsies following radiotherapy for prostate cancer: results for 226 patients</title> <source>Urology</source> <year>1995</year> <volume>45</volume> <fpage>624</fpage> - <lpage>31</lpage>
<author><surname>Siddiqui</surname> <given-names>SA</given-names></author> <author><surname>Mynderse</surname> <given-names>LA</given-names></author> <author><surname>Zincke</surname> <given-names>H</given-names></author> <title>Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience</title> <source>Urology</source> <year>2007</year> <volume>70</volume> <fpage>80</fpage> - <lpage>5</lpage>
<author><surname>Chin</surname> <given-names>JL</given-names></author> <author><surname>Lim</surname> <given-names>D</given-names></author> <author><surname>Abdelhady</surname> <given-names>M</given-names></author> <title>Review of primary and salvage cryoablation for prostate cancer</title> <source>Cancer Control</source> <year>2007</year> <volume>14</volume> <fpage>231</fpage> - <lpage>7</lpage>
<author><surname>Finley</surname> <given-names>DS</given-names></author> <author><surname>Pouliot</surname> <given-names>F</given-names></author> <author><surname>Miller</surname> <given-names>DR</given-names></author> <author><surname>Belldegrun</surname> <given-names>AS</given-names></author> <title>Primary and salvage cryotherapy for prostate cancer</title> <source>Urol Clin North Am</source> <year>2010</year> <volume>37</volume> <fpage>67</fpage> - <lpage>82</lpage>
<author><surname>Babaian</surname> <given-names>RJ</given-names></author> <author><surname>Donnelly</surname> <given-names>B</given-names></author> <author><surname>Bahn</surname> <given-names>D</given-names></author> <title>AUA Best practice statement on cryosurgery for the treatment of localized prostate cancer</title> <source>J Urol</source> <year>2008</year> <volume>180</volume> <fpage>1993</fpage> - <lpage>2004</lpage>
<author><surname>Nguyen</surname> <given-names>PL</given-names></author> <author><surname>D"Amico</surname> <given-names>AV</given-names></author> <author><surname>Lee</surname> <given-names>AK</given-names></author> <author><surname>Suh</surname> <given-names>WW</given-names></author> <title>Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature</title> <source>Cancer</source> <year>2007</year> <volume>110</volume> <fpage>1417</fpage> - <lpage>28</lpage>
<author><surname>Spiess</surname> <given-names>PE</given-names></author> <author><surname>Lee</surname> <given-names>AK</given-names></author> <author><surname>Leibovici</surname> <given-names>D</given-names></author> <title>Presalvage prostate-specific antigen and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy</title> <source>Cancer</source> <year>2006</year> <volume>107</volume> <fpage>275</fpage> - <lpage>80</lpage>
<author><surname>Vergunst</surname> <given-names>H</given-names></author> <author><surname>Langenhuijsen</surname> <given-names>JF</given-names></author> <title>Rebuttal from Authors re: J. Stephen Jones. Ten Misconceptions regarding cryotherapy for prostate cancer</title> <source>Eur Urol</source> <year>2009</year> <volume>55</volume> <fpage>52</fpage> - <lpage>5</lpage>
<author><surname>Chin</surname> <given-names>JL</given-names></author> <author><surname>Pautler</surname> <given-names>SE</given-names></author> <author><surname>Mouraviev</surname> <given-names>V</given-names></author> <title>Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications</title> <source>J Urol</source> <year>2001</year> <volume>165</volume> <fpage>1937</fpage> - <lpage>42</lpage>
<author><surname>Taille</surname> <given-names>A</given-names></author> <author><surname>Benson</surname> <given-names>MC</given-names></author> <author><surname>Bagiella</surname> <given-names>E</given-names></author> <title>Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence</title> <source>BJU Int</source> <year>2000</year> <volume>85</volume> <fpage>281</fpage> - <lpage>6</lpage>
<author><surname>Izawa</surname> <given-names>JI</given-names></author> <author><surname>Madsen</surname> <given-names>LT</given-names></author> <author><surname>Scott</surname> <given-names>SM</given-names></author> <title>Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome</title> <source>J Clin Oncol</source> <year>2002</year> <volume>20</volume> <fpage>2664</fpage> - <lpage>71</lpage>
<author><surname>Pisters</surname> <given-names>LL</given-names></author> <author><surname>Perrotte</surname> <given-names>P</given-names></author> <author><surname>Scott</surname> <given-names>SM</given-names></author> <title>Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy</title> <source>J Clin Oncol</source> <year>1999</year> <volume>17</volume> <fpage>2514</fpage> - <lpage>20</lpage>
<author><surname>Spiess</surname> <given-names>PE</given-names></author> <author><surname>Katz</surname> <given-names>AE</given-names></author> <author><surname>Chin</surname> <given-names>JL</given-names></author> <title>A pretreatment nomogram predicting biochemical failure after salvage cryotherapy for locally recurrent prostate cancer</title> <source>BJU Int</source> <year>2009</year> <volume>106</volume> <fpage>194</fpage> - <lpage>8</lpage>
<author><surname>Bahn</surname> <given-names>DK</given-names></author> <author><surname>Lee</surname> <given-names>F</given-names></author> <author><surname>Silverman</surname> <given-names>P</given-names></author> <title>Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up</title> <source>Clin Prostate Cancer</source> <year>2003</year> <volume>2</volume> <fpage>111</fpage> - <lpage>4</lpage>
<author><surname>Cheetham</surname> <given-names>P</given-names></author> <author><surname>Truesdale</surname> <given-names>M</given-names></author> <author><surname>Chaudhury</surname> <given-names>S</given-names></author> <title>Long-term cancer-specific and overall survival for men followed more than 10 years after primary and salvage cryoablation of the prostate</title> <source>J Endo</source> <year>2010</year> <volume>24</volume> <fpage>1123</fpage> - <lpage>9</lpage>
<author><surname>Huang</surname> <given-names>WC</given-names></author> <author><surname>Kuroiwa</surname> <given-names>K</given-names></author> <author><surname>Serio</surname> <given-names>AM</given-names></author> <title>The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies</title> <source>J Urol</source> <year>2007</year> <volume>177</volume> <fpage>1324</fpage> - <lpage>9</lpage>
<author><surname>Klossner</surname> <given-names>DP</given-names></author> <author><surname>Baust</surname> <given-names>JM</given-names></author> <author><surname>VanBuskirk</surname> <given-names>RG</given-names></author> <author><surname>Gage</surname> <given-names>AA</given-names></author> <author><surname>Baust</surname> <given-names>JG</given-names></author> <title>Cryoablative response of prostate cancer cells is influenced by androgen receptor expression</title> <source>BJU Int</source> <year>2008</year> <volume>101</volume> <fpage>1310</fpage> - <lpage>6</lpage>
<author><surname>Eisenberg</surname> <given-names>ML</given-names></author> <author><surname>Shinohara</surname> <given-names>K</given-names></author> <title>Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure</title> <source>Urology</source> <year>2008</year> <volume>72</volume> <fpage>1315</fpage> - <lpage>8</lpage>
<author><surname>Abdelhady</surname> <given-names>M</given-names></author> <author><surname>Abusamra</surname> <given-names>A</given-names></author> <author><surname>Elmaadawi</surname> <given-names>A</given-names></author> <title>Health related quality of life (HRQOL) outcome after salvage cryosurgery of the prostate: comparison with outcome after primary radiotherapy</title> <source>J Urol suppl</source> <year>2007</year> <volume>177</volume> <fpage>3</fpage>
<author><surname>Robinson</surname> <given-names>JW</given-names></author> <author><surname>Donnelly</surname> <given-names>BJ</given-names></author> <author><surname>Coupland</surname> <given-names>K</given-names></author> <title>Quality of life 2 years after salvage cryosurgery for the treatment of local recurrence of prostate cancer after radiotherapy</title> <source>Urol Oncol</source> <year>2006</year> <volume>24</volume> <fpage>472</fpage> - <lpage>86</lpage>
<author><surname>Perrotte</surname> <given-names>P</given-names></author> <author><surname>Litwin</surname> <given-names>M</given-names></author> <author><surname>McGuire</surname> <given-names>EJ</given-names></author> <title>Quality of life after salvage cryotherapy: the impact of treatment parameters</title> <source>J Urol</source> <year>1999</year> <volume>162</volume> <fpage>398</fpage> - <lpage>402</lpage>
<author><surname>Levy</surname> <given-names>DA</given-names></author> <title>Correlation of thermocouple data with voiding function after prostate cryoablation</title> <source>Urology</source> <year>2010</year> <volume>75</volume> <fpage>482</fpage> - <lpage>7</lpage>
<author><surname>Taille</surname> <given-names>A</given-names></author> <author><surname>Hayek</surname> <given-names>O</given-names></author> <author><surname>Benson</surname> <given-names>MC</given-names></author> <title>Salvage cryotherapy for recurrent prostate cancer after radiation treatment: the Columbia experience</title> <source>Urology</source> <year>2000</year> <volume>55</volume> <fpage>79</fpage> - <lpage>84</lpage>
<author><surname>Long</surname> <given-names>JP</given-names></author> <author><surname>Fallick</surname> <given-names>ML</given-names></author> <author><surname>LaRock</surname> <given-names>DR</given-names></author> <author><surname>Rand</surname> <given-names>W</given-names></author> <title>Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma</title> <source>J Urol</source> <year>1998</year> <volume>159</volume> <fpage>477</fpage> - <lpage>84</lpage>
<author><surname>Anastasiadis</surname> <given-names>AG</given-names></author> <author><surname>Sachdev</surname> <given-names>R</given-names></author> <author><surname>Salomon</surname> <given-names>L</given-names></author> <title>Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer</title> <source>J Cancer Res Clin Oncol</source> <year>2003</year> <volume>129</volume> <fpage>676</fpage> - <lpage>82</lpage>
<author><surname>Ismail</surname> <given-names>M</given-names></author> <author><surname>Ahmed</surname> <given-names>S</given-names></author> <author><surname>Kastner</surname> <given-names>C</given-names></author> <author><surname>Davies</surname> <given-names>J</given-names></author> <title>Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients</title> <source>BJU Int</source> <year>2007</year> <volume>100</volume> <fpage>760</fpage> - <lpage>4</lpage>
<author><surname>Pisters</surname> <given-names>LL</given-names></author> <author><surname>Rewcastle</surname> <given-names>JC</given-names></author> <author><surname>Donnelly</surname> <given-names>BJ</given-names></author> <title>Salvage prostate cryoablation: initial results from the cryo on-line data registry</title> <source>J Urol</source> <year>2008</year> <volume>180</volume> <fpage>559</fpage> - <lpage>64</lpage>
<author><surname>Bucholz</surname> <given-names>RW</given-names></author> <title>Nonallograft osteoconductive bone graft substitutes</title> <source>Clin Orthop Relat Res</source> <year>2002</year> <volume>395</volume> <issue>395</issue> <fpage>44</fpage> - <lpage>52</lpage>
<author><surname>Burger</surname> <given-names>EL</given-names></author> <author><surname>Patel</surname> <given-names>V</given-names></author> <title>Calcium phosphates as bone graft extenders</title> <source>Orthopedics</source> <year>2007</year> <volume>30</volume> <issue>11</issue> <fpage>939</fpage> - <lpage>942</lpage>
<author><surname>Moore</surname> <given-names>WR</given-names></author> <author><surname>Graves</surname> <given-names>SE</given-names></author> <author><surname>Bain</surname> <given-names>GI</given-names></author> <title>Synthetic bone graft substitutes</title> <source>ANZ J Surg</source> <year>2001</year> <volume>71</volume> <issue>6</issue> <fpage>354</fpage> - <lpage>361</lpage>
<author><surname>Chang</surname> <given-names>BS</given-names></author> <author><surname>Lee</surname> <given-names>CK</given-names></author> <author><surname>Hong</surname> <given-names>KS</given-names></author> <author><surname>Youn</surname> <given-names>HJ</given-names></author> <author><surname>Ryu</surname> <given-names>HS</given-names></author> <author><surname>Chung</surname> <given-names>SS</given-names></author> <title>Osteoconduction at porous hydroxyapatite with various pore configurations</title> <source>Biomaterials</source> <year>2000</year> <volume>21</volume> <issue>12</issue> <fpage>1291</fpage> - <lpage>1298</lpage>
<author><surname>Groot</surname> <given-names>K</given-names></author> <title>Bioceramics consisting of calcium phosphate salts</title> <source>Biomaterials</source> <year>1980</year> <volume>1</volume> <issue>1</issue> <fpage>47</fpage> - <lpage>50</lpage>
<author><surname>Gauthier</surname> <given-names>O</given-names></author> <author><surname>Bouler</surname> <given-names>JM</given-names></author> <author><surname>Aguado</surname> <given-names>E</given-names></author> <author><surname>Pilet</surname> <given-names>P</given-names></author> <author><surname>Daculsi</surname> <given-names>G</given-names></author> <title>Macroporous biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone ingrowth</title> <source>Biomaterials</source> <year>1998</year> <volume>19</volume> <issue>1&#8211;3</issue> <fpage>133</fpage> - <lpage>139</lpage>
<author><surname>Holmes</surname> <given-names>RE</given-names></author> <author><surname>Brighton</surname> <given-names>CT</given-names></author>, <author><surname>Friedlaender</surname> <given-names>G</given-names></author> <author><surname>Lane</surname> <given-names>JM</given-names></author> <title>Osteoconduction in hydroxyapatite-based materials</title> <source>Bone formation and repair</source> <year>1994</year> <other>Rosemont</other> <publisher>American Academy</publisher> of Orthopedic Surgeons 355-365
<author><surname>Ripamonti</surname> <given-names>U</given-names></author> <title>Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models</title> <source>Biomaterials</source> <year>1996</year> <volume>17</volume> <issue>1</issue> <fpage>31</fpage> - <lpage>35</lpage>
<author><surname>Yuan</surname> <given-names>H</given-names></author> <author><surname>Bruijn</surname> <given-names>JD</given-names></author> <author><surname>Zhang</surname> <given-names>X</given-names></author> <author><surname>Blitterswijk</surname> <given-names>CA</given-names></author> <author><surname>Groot</surname> <given-names>K</given-names></author> <title>Bone induction by porous glass ceramic made from Bioglass (45S5</title>) <source>J Biomed Mater Res</source> <year>2001</year> <volume>58</volume> <issue>3</issue> <fpage>270</fpage> - <lpage>276</lpage>
<author><surname>Yuan</surname> <given-names>H</given-names></author> <author><surname>Kurashina</surname> <given-names>K</given-names></author> <author><surname>Bruijn</surname> <given-names>JD</given-names></author> <author><surname>Li</surname> <given-names>Y</given-names></author> <author><surname>Groot</surname> <given-names>K</given-names></author> <author><surname>Zhang</surname> <given-names>X</given-names></author> <title>A preliminary study on osteoinduction of two kinds of calcium phosphate ceramics</title> <source>Biomaterials</source> <year>1999</year> <volume>20</volume> <issue>19</issue> <fpage>1799</fpage> - <lpage>1806</lpage>
<author><surname>Habibovic</surname> <given-names>P</given-names></author> <author><surname>Gbureck</surname> <given-names>U</given-names></author> <author><surname>Doillon</surname> <given-names>CJ</given-names></author> <author><surname>Bassett</surname> <given-names>DC</given-names></author> <author><surname>Blitterswijk</surname> <given-names>CA</given-names></author> <author><surname>Barralet</surname> <given-names>JE</given-names></author> <title>Osteoconduction and osteoinduction of low-temperature 3D printed bioceramic implants</title> <source>Biomaterials</source> <year>2008</year> <volume>29</volume> <issue>7</issue> <fpage>944</fpage> - <lpage>953</lpage>
<author><surname>Habibovic</surname> <given-names>P</given-names></author> <author><surname>Kruyt</surname> <given-names>MC</given-names></author> <author><surname>Juhl</surname> <given-names>MV</given-names></author> <author><surname>Clyens</surname> <given-names>S</given-names></author> <author><surname>Martinetti</surname> <given-names>R</given-names></author> <author><surname>Dolcini</surname> <given-names>L</given-names></author> <title>Comparative in vivo study of six hydroxyapatite-based bone graft substitutes</title> <source>J Orthop Res</source> <year>2008</year> <volume>26</volume> <issue>10</issue> <fpage>1363</fpage> - <lpage>1370</lpage>
<author><surname>Anselme</surname> <given-names>K</given-names></author> <author><surname>Noel</surname> <given-names>B</given-names></author> <author><surname>Flautre</surname> <given-names>B</given-names></author> <author><surname>Blary</surname> <given-names>MC</given-names></author> <author><surname>Delecourt</surname> <given-names>C</given-names></author> <author><surname>Descamps</surname> <given-names>M</given-names></author> <title>Association of porous hydroxyapatite and bone marrow cells for bone regeneration</title> <source>Bone</source> <year>1999</year> <volume>25</volume> <issue>2 Suppl</issue> <fpage>51</fpage> - <lpage>54</lpage> - <lpage></lpage>
<author><surname>Bruijn</surname> <given-names>JD</given-names></author> <author><surname>Brink</surname> <given-names>I</given-names></author> <author><surname>Mendes</surname> <given-names>S</given-names></author> <author><surname>Dekker</surname> <given-names>R</given-names></author> <author><surname>Bovell</surname> <given-names>YP</given-names></author> <author><surname>Blitterswijk</surname> <given-names>CA</given-names></author> <title>Bone induction by implants coated with cultured osteogenic bone marrow cells</title> <source>Adv Dent Res</source> <year>1999</year> <volume>13</volume> <fpage>74</fpage> - <lpage>81</lpage>
<author><surname>Goshima</surname> <given-names>J</given-names></author> <author><surname>Goldberg</surname> <given-names>VM</given-names></author> <author><surname>Caplan</surname> <given-names>AI</given-names></author> <title>The osteogenic potential of culture-expanded rat marrow mesenchymal cells assayed in vivo in calcium phosphate ceramic blocks</title> <source>Clin Orthop Relat Res</source> <year>1991</year> <volume>262</volume> <fpage>298</fpage> - <lpage>311</lpage>
<author><surname>Ohgushi</surname> <given-names>H</given-names></author> <author><surname>Okumura</surname> <given-names>M</given-names></author> <author><surname>Tamai</surname> <given-names>S</given-names></author> <author><surname>Shors</surname> <given-names>EC</given-names></author> <author><surname>Caplan</surname> <given-names>AI</given-names></author> <title>Marrow cell induced osteogenesis in porous hydroxyapatite and tricalcium phosphate: a comparative histomorphometric study of ectopic bone formation</title> <source>J Biomed Mater Res</source> <year>1990</year> <volume>24</volume> <issue>12</issue> <fpage>1563</fpage> - <lpage>1570</lpage>
<author><surname>Roy</surname> <given-names>DM</given-names></author> <author><surname>Linnehan</surname> <given-names>SK</given-names></author> <title>Hydroxyapatite formed from coral skeletal carbonate by hydrothermal exchange</title> <source>Nature</source> <year>1974</year> <volume>247</volume> <issue>438</issue> <fpage>220</fpage> - <lpage>222</lpage>
<author><surname>White</surname> <given-names>RA</given-names></author> <author><surname>Weber</surname> <given-names>JN</given-names></author> <author><surname>White</surname> <given-names>EW</given-names></author> <title>Replamineform: a new process for preparing porous ceramic, metal, and polymer prosthetic materials</title> <source>Science</source> <year>1972</year> <volume>176</volume> <issue>37</issue> <fpage>922</fpage> - <lpage>924</lpage>
<author><surname>Lin</surname> <given-names>FH</given-names></author> <author><surname>Liao</surname> <given-names>CJ</given-names></author> <author><surname>Chen</surname> <given-names>KS</given-names></author> <author><surname>Sun</surname> <given-names>JS</given-names></author> <author><surname>Lin</surname> <given-names>CY</given-names></author> <title>Preparation of betaTCP/HAP biphasic ceramics with natural bone structure by heating bovine cancellous bone with the addition of (NH (4))(2) HPO (4</title>) <source>J Biomed Mater Res</source> <year>2000</year> <volume>51</volume> <issue>2</issue> <fpage>157</fpage> - <lpage>163</lpage>
<author><surname>Tancred</surname> <given-names>DC</given-names></author> <author><surname>McCormack</surname> <given-names>BA</given-names></author> <author><surname>Carr</surname> <given-names>AJ</given-names></author> <title>A synthetic bone implant macroscopically identical to cancellous bone</title> <source>Biomaterials</source> <year>1998</year> <volume>19</volume> <issue>24</issue> <fpage>2303</fpage> - <lpage>2311</lpage>
<author><surname>Rejda</surname> <given-names>BV</given-names></author> <author><surname>Peelen</surname> <given-names>JG</given-names></author> <author><surname>Groot</surname> <given-names>K</given-names></author> <title>Tri-calcium phosphate as a bone substitute</title> <source>J Bioeng</source> <year>1977</year> <volume>1</volume> <issue>2</issue> <fpage>93</fpage> - <lpage>97</lpage>
<author><surname>Sepulveda</surname> <given-names>P</given-names></author> <author><surname>Binner</surname> <given-names>JG</given-names></author> <author><surname>Rogero</surname> <given-names>SO</given-names></author> <author><surname>Higa</surname> <given-names>OZ</given-names></author> <author><surname>Bressiani</surname> <given-names>JC</given-names></author> <title>Production of porous hydroxyapatite by the gel-casting of foams and cytotoxic evaluation</title> <source>J Biomed Mater Res</source> <year>2000</year> <volume>50</volume> <issue>1</issue> <fpage>27</fpage> - <lpage>34</lpage>
<author><surname>Tamai</surname> <given-names>N</given-names></author> <author><surname>Myoui</surname> <given-names>A</given-names></author> <author><surname>Tomita</surname> <given-names>T</given-names></author> <author><surname>Nakase</surname> <given-names>T</given-names></author> <author><surname>Tanaka</surname> <given-names>J</given-names></author> <author><surname>Ochi</surname> <given-names>T</given-names></author> <title>Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo</title> <source>J Biomed Mater Res</source> <year>2002</year> <volume>59</volume> <issue>1</issue> <fpage>110</fpage> - <lpage>117</lpage>
<author><surname>Li</surname> <given-names>SH</given-names></author> <author><surname>Wijn</surname> <given-names>JR</given-names></author> <author><surname>Layrolle</surname> <given-names>P</given-names></author> <author><surname>Groot</surname> <given-names>K</given-names></author> <title>Synthesis of macroporous hydroxyapatite scaffolds for bone tissue engineering</title> <source>J Biomed Mater Res</source> <year>2002</year> <volume>61</volume> <issue>1</issue> <fpage>109</fpage> - <lpage>120</lpage>
<author><surname>Bouler</surname> <given-names>JM</given-names></author> <author><surname>Trecant</surname> <given-names>M</given-names></author> <author><surname>Delecrin</surname> <given-names>J</given-names></author> <author><surname>Royer</surname> <given-names>J</given-names></author> <author><surname>Passuti</surname> <given-names>N</given-names></author> <author><surname>Daculsi</surname> <given-names>G</given-names></author> <title>Macroporous biphasic calcium phosphate ceramics: influence of five synthesis parameters on compressive strength</title> <source>J Biomed Mater Res</source> <year>1996</year> <volume>32</volume> <issue>4</issue> <fpage>603</fpage> - <lpage>609</lpage>
<author><surname>Tsuruga</surname> <given-names>E</given-names></author> <author><surname>Takita</surname> <given-names>H</given-names></author> <author><surname>Itoh</surname> <given-names>H</given-names></author> <author><surname>Wakisaka</surname> <given-names>Y</given-names></author> <author><surname>Kuboki</surname> <given-names>Y</given-names></author> <title>Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis</title> <source>J Biochem (Tokyo)</source> <year>1997</year> <volume>121</volume> <issue>2</issue> <fpage>317</fpage> - <lpage>324</lpage>
<author><surname>Woyansky</surname> <given-names>JS</given-names></author> <author><surname>Scott</surname> <given-names>CE</given-names></author> <author><surname>Minnear</surname> <given-names>WP</given-names></author> <title>Processing of porous ceramics</title> <source>Am Ceram Soc Bull</source> <year>1992</year> <volume>71</volume> <fpage>1674</fpage> - <lpage>1682</lpage>
<author><surname>Bloebaum</surname> <given-names>RD</given-names></author> <author><surname>Bachus</surname> <given-names>KN</given-names></author> <author><surname>Momberger</surname> <given-names>NG</given-names></author> <author><surname>Hofmann</surname> <given-names>AA</given-names></author> <title>Mineral apposition rates of human cancellous bone at the interface of porous coated implants</title> <source>J Biomed Mater Res</source> <year>1994</year> <volume>28</volume> <issue>5</issue> <fpage>537</fpage> - <lpage>544</lpage>
<author><surname>Eggli</surname> <given-names>PS</given-names></author> <author><surname>Muller</surname> <given-names>W</given-names></author> <author><surname>Schenk</surname> <given-names>RK</given-names></author> <title>Porous hydroxyapatite and tricalcium phosphate cylinders with two different pore size ranges implanted in the cancellous bone of rabbits. A comparative histomorphometric and histologic study of bony ingrowth and implant substitution</title> <source>Clin Orthop Relat Res</source> <year>1988</year> <volume>232</volume> <fpage>127</fpage> - <lpage>138</lpage>
<author><surname>Hofmann</surname> <given-names>AA</given-names></author> <author><surname>Bloebaum</surname> <given-names>RD</given-names></author> <author><surname>Bachus</surname> <given-names>KN</given-names></author> <title>Progression of human bone ingrowth into porous-coated implants. Rate of bone ingrowth in humans</title> <source>Acta Orthop Scand</source> <year>1997</year> <volume>68</volume> <issue>2</issue> <fpage>161</fpage> - <lpage>166</lpage>
<author><surname>Hulbert</surname> <given-names>SF</given-names></author> <author><surname>Young</surname> <given-names>FA</given-names></author> <author><surname>Mathews</surname> <given-names>RS</given-names></author> <author><surname>Klawitter</surname> <given-names>JJ</given-names></author> <author><surname>Talbert</surname> <given-names>CD</given-names></author> <author><surname>Stelling</surname> <given-names>FH</given-names></author> <title>Potential of ceramic materials as permanently implantable skeletal prostheses</title> <source>J Biomed Mater Res</source> <year>1970</year> <volume>4</volume> <issue>3</issue> <fpage>433</fpage> - <lpage>456</lpage>
<author><surname>Karageorgiou</surname> <given-names>V</given-names></author> <author><surname>Kaplan</surname> <given-names>D</given-names></author> <title>Porosity of 3D biomaterial scaffolds and osteogenesis</title> <source>Biomaterials</source> <year>2005</year> <volume>26</volume> <fpage>5474</fpage> - <lpage>5491</lpage>
<author><surname>Kuhne</surname> <given-names>JH</given-names></author> <author><surname>Bartl</surname> <given-names>R</given-names></author> <author><surname>Frisch</surname> <given-names>B</given-names></author> <author><surname>Hammer</surname> <given-names>C</given-names></author> <author><surname>Jansson</surname> <given-names>V</given-names></author> <author><surname>Zimmer</surname> <given-names>M</given-names></author> <title>Bone formation in coralline hydroxyapatite. Effects of pore size studied in rabbits</title> <source>Acta Orthop Scand</source> <year>1994</year> <volume>65</volume> <issue>3</issue> <fpage>246</fpage> - <lpage>252</lpage>
<author><surname>Schliephake</surname> <given-names>H</given-names></author> <author><surname>Neukam</surname> <given-names>FW</given-names></author> <author><surname>Klosa</surname> <given-names>D</given-names></author> <title>Influence of pore dimensions on bone ingrowth into porous hydroxylapatite blocks used as bone graft substitutes. A histometric study</title> <source>Int J Oral Maxillofac Surg</source> <year>1991</year> <volume>20</volume> <issue>1</issue> <fpage>53</fpage> - <lpage>58</lpage>
<author><surname>Hing</surname> <given-names>KA</given-names></author> <author><surname>Best</surname> <given-names>SM</given-names></author> <author><surname>Tanner</surname> <given-names>KE</given-names></author> <author><surname>Bonfield</surname> <given-names>W</given-names></author> <author><surname>Revell</surname> <given-names>PA</given-names></author> <title>Mediation of bone ingrowth in porous hydroxyapatite bone graft substitutes</title> <source>J Biomed Mater Res A</source> <year>2004</year> <volume>68</volume> <issue>1</issue> <fpage>187</fpage> - <lpage>200</lpage>
<author><surname>Jin</surname> <given-names>QM</given-names></author> <author><surname>Takita</surname> <given-names>H</given-names></author> <author><surname>Kohgo</surname> <given-names>T</given-names></author> <author><surname>Atsumi</surname> <given-names>K</given-names></author> <author><surname>Itoh</surname> <given-names>H</given-names></author> <author><surname>Kuboki</surname> <given-names>Y</given-names></author> <title>Effects of geometry of hydroxyapatite as a cell substratum in BMP-induced ectopic bone formation</title> <source>J Biomed Mater Res</source> <year>2000</year> <volume>52</volume> <issue>4</issue> <fpage>491</fpage> - <lpage>499</lpage>
<author><surname>Kuboki</surname> <given-names>Y</given-names></author> <author><surname>Takita</surname> <given-names>H</given-names></author> <author><surname>Kobayashi</surname> <given-names>D</given-names></author> <author><surname>Tsuruga</surname> <given-names>E</given-names></author> <author><surname>Inoue</surname> <given-names>M</given-names></author> <author><surname>Murata</surname> <given-names>M</given-names></author> <title>BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: topology of osteogenesis</title> <source>J Biomed Mater Res</source> <year>1998</year> <volume>39</volume> <issue>2</issue> <fpage>190</fpage> - <lpage>199</lpage>
<author><surname>Ripamonti</surname> <given-names>U</given-names></author> <author><surname>Ma</surname> <given-names>S</given-names></author> <author><surname>Reddi</surname> <given-names>AH</given-names></author> <title>The critical role of geometry of porous hydroxyapatite delivery system in induction of bone by osteogenin, a bone morphogenetic protein</title> <source>Matrix</source> <year>1992</year> <volume>12</volume> <issue>3</issue> <fpage>202</fpage> - <lpage>212</lpage>
<author><surname>Habibovic</surname> <given-names>P</given-names></author> <author><surname>Groot</surname> <given-names>K</given-names></author> <title>Osteoinductive biomaterials&#8212;properties and relevance in bone repair</title> <source>J Tissue Eng Regen Med</source> <year>2007</year> <volume>1</volume> <issue>1</issue> <fpage>25</fpage> - <lpage>32</lpage>
<author><surname>Hutmacher</surname> <given-names>DW</given-names></author> <title>Scaffold design and fabrication technologies for engineering tissues&#8212;state of the art and future perspectives</title> <source>J Biomater Sci Polym Ed</source> <year>2001</year> <volume>12</volume> <issue>1</issue> <fpage>107</fpage> - <lpage>124</lpage>
<author><surname>Yang</surname> <given-names>S</given-names></author> <author><surname>Leong</surname> <given-names>KF</given-names></author> <author><surname>Du</surname> <given-names>Z</given-names></author> <author><surname>Chua</surname> <given-names>CK</given-names></author> <title>The design of scaffolds for use in tissue engineering. Part II. Rapid prototyping techniques</title> <source>Tissue Eng</source> <year>2002</year> <volume>8</volume> <issue>1</issue> <fpage>1</fpage> - <lpage>11</lpage>
<author><surname>Hollister</surname> <given-names>SJ</given-names></author> <title>Porous scaffold design for tissue engineering</title> <source>Nat Mater</source> <year>2005</year> <volume>4</volume> <issue>7</issue> <fpage>518</fpage> - <lpage>524</lpage>
<author><surname>Chim</surname> <given-names>H</given-names></author> <author><surname>Schantz</surname> <given-names>JT</given-names></author> <title>New frontiers in calvarial reconstruction: integrating computer-assisted design and tissue engineering in cranioplasty</title> <source>Plast Reconstr Surg</source> <year>2005</year> <volume>116</volume> <issue>6</issue> <fpage>1726</fpage> - <lpage>1741</lpage>
<author><surname>Chu</surname> <given-names>TM</given-names></author> <author><surname>Orton</surname> <given-names>DG</given-names></author> <author><surname>Hollister</surname> <given-names>SJ</given-names></author> <author><surname>Feinberg</surname> <given-names>SE</given-names></author> <author><surname>Halloran</surname> <given-names>JW</given-names></author> <title>Mechanical and in vivo performance of hydroxyapatite implants with controlled architectures</title> <source>Biomaterials</source> <year>2002</year> <volume>23</volume> <issue>5</issue> <fpage>1283</fpage> - <lpage>1293</lpage>
<author><surname>Levy</surname> <given-names>RA</given-names></author> <author><surname>Chu</surname> <given-names>TM</given-names></author> <author><surname>Halloran</surname> <given-names>JW</given-names></author> <author><surname>Feinberg</surname> <given-names>SE</given-names></author> <author><surname>Hollister</surname> <given-names>S</given-names></author> <title>CT-generated porous hydroxyapatite orbital floor prosthesis as a prototype bioimplant AJNR</title> <source>Am J Neuroradiol</source> <year>1997</year> <volume>18</volume> <issue>8</issue> <fpage>1522</fpage> - <lpage>1525</lpage>
<author><surname>Chu</surname> <given-names>TM</given-names></author> <author><surname>Halloran</surname> <given-names>JW</given-names></author> <author><surname>Hollister</surname> <given-names>SJ</given-names></author> <author><surname>Feinberg</surname> <given-names>SE</given-names></author> <title>Hydroxyapatite implants with designed internal architecture</title> <source>J Mater Sci Mater Med</source> <year>2001</year> <volume>12</volume> <issue>6</issue> <fpage>471</fpage> - <lpage>478</lpage>
<author><surname>Dutta Roy</surname> <given-names>T</given-names></author> <author><surname>Simon</surname> <given-names>JL</given-names></author> <author><surname>Ricci</surname> <given-names>JL</given-names></author> <author><surname>Rekow</surname> <given-names>ED</given-names></author> <author><surname>Thompson</surname> <given-names>VP</given-names></author> <author><surname>Parsons</surname> <given-names>JR</given-names></author> <title>Performance of hydroxyapatite bone repair scaffolds created via three-dimensional fabrication techniques</title> <source>J Biomed Mater Res A</source> <year>2003</year> <volume>67</volume> <issue>4</issue> <fpage>1228</fpage> - <lpage>1237</lpage>
<author><surname>Seitz</surname> <given-names>H</given-names></author> <author><surname>Rieder</surname> <given-names>W</given-names></author> <author><surname>Irsen</surname> <given-names>S</given-names></author> <author><surname>Leukers</surname> <given-names>B</given-names></author> <author><surname>Tille</surname> <given-names>C</given-names></author> <title>Three-dimensional printing of porous ceramic scaffolds for bone tissue engineering</title> <source>J Biomed Mater Res B Appl Biomater</source> <year>2005</year> <volume>74</volume> <issue>2</issue> <fpage>782</fpage> - <lpage>788</lpage>
<author><surname>Wilson</surname> <given-names>CE</given-names></author> <author><surname>Bruijn</surname> <given-names>JD</given-names></author> <author><surname>Blitterswijk</surname> <given-names>CA</given-names></author> <author><surname>Verbout</surname> <given-names>AJ</given-names></author> <author><surname>Dhert</surname> <given-names>WJ</given-names></author> <title>Design and fabrication of standardized hydroxyapatite scaffolds with a defined macro-architecture by rapid prototyping for bone-tissue-engineering research</title> <source>J Biomed Mater Res</source> <year>2004</year> <volume>68A</volume> <issue>1</issue> <fpage>123</fpage> - <lpage>132</lpage>
<author><surname>Wilson</surname> <given-names>CE</given-names></author> <author><surname>Kruyt</surname> <given-names>MC</given-names></author> <author><surname>Bruijn</surname> <given-names>JD</given-names></author> <author><surname>Blitterswijk</surname> <given-names>CA</given-names></author> <author><surname>Oner</surname> <given-names>FC</given-names></author> <author><surname>Verbout</surname> <given-names>AJ</given-names></author> <title>A new in vivo screening model for posterior spinal bone formation: comparison of ten calcium phosphate ceramic material treatments</title> <source>Biomaterials</source> <year>2006</year> <volume>27</volume> <issue>3</issue> <fpage>302</fpage> - <lpage>314</lpage>
<author><surname>Geuze</surname> <given-names>RE</given-names></author> <author><surname>Kruyt</surname> <given-names>MC</given-names></author> <author><surname>Verbout</surname> <given-names>AJ</given-names></author> <author><surname>Alblas</surname> <given-names>J</given-names></author> <author><surname>Dhert</surname> <given-names>WJ</given-names></author> <title>Comparing various off-the-shelf methods for bone tissue engineering in a large-animal ectopic implantation model: bone marrow, allogeneic bone marrow stromal cells, and platelet gel</title> <source>Tissue Eng Part A</source> <year>2008</year> <volume>14</volume> <issue>8</issue> <fpage>1435</fpage> - <lpage>1443</lpage>
<author><surname>Kruyt</surname> <given-names>M</given-names></author> <author><surname>Bruijn</surname> <given-names>J</given-names></author> <author><surname>Rouwkema</surname> <given-names>J</given-names></author> <author><surname>Blitterswijk</surname> <given-names>C</given-names></author> <author><surname>Oner</surname> <given-names>C</given-names></author> <author><surname>Verbout</surname> <given-names>A</given-names></author> <title>Analysis of the dynamics of bone formation, effect of cell seeding density, and potential of allogeneic cells in cell-based bone tissue engineering in goats</title> <source>Tissue Eng Part A</source> <year>2008</year> <volume>14</volume> <issue>6</issue> <fpage>1081</fpage> - <lpage>1088</lpage>
<author><surname>Kruyt</surname> <given-names>MC</given-names></author> <author><surname>Dhert</surname> <given-names>WJ</given-names></author> <author><surname>Oner</surname> <given-names>FC</given-names></author> <author><surname>Blitterswijk</surname> <given-names>CA</given-names></author> <author><surname>Verbout</surname> <given-names>AJ</given-names></author> <author><surname>Bruijn</surname> <given-names>JD</given-names></author> <title>Analysis of ectopic and orthotopic bone formation in cell-based tissue-engineered constructs in goats</title> <source>Biomaterials</source> <year>2007</year> <volume>28</volume> <issue>10</issue> <fpage>1798</fpage> - <lpage>1805</lpage>
<author><surname>Kruyt</surname> <given-names>MC</given-names></author> <author><surname>Wilson</surname> <given-names>CE</given-names></author> <author><surname>Bruijn</surname> <given-names>JD</given-names></author> <author><surname>Blitterswijk</surname> <given-names>CA</given-names></author> <author><surname>Oner</surname> <given-names>CF</given-names></author> <author><surname>Verbout</surname> <given-names>AJ</given-names></author> <title>The effect of cell-based bone tissue engineering in a goat transverse process model</title> <source>Biomaterials</source> <year>2006</year> <volume>27</volume> <issue>29</issue> <fpage>5099</fpage> - <lpage>5106</lpage>
<author><surname>Nackaerts</surname> <given-names>K</given-names></author> <author><surname>Axelson</surname> <given-names>O</given-names></author> <author><surname>Brambilla</surname> <given-names>E</given-names></author> <author><surname>Bromen</surname> <given-names>K</given-names></author> <author><surname>Hirsch</surname> <given-names>FR</given-names></author> <author><surname>Nemery</surname> <given-names>B</given-names></author> <author><surname>Petit</surname> <given-names>MR</given-names></author> <title>Sasco AJ van</title> <source>Meerbeeck J</source> <author><surname>van Zandwijk</surname> <given-names>N</given-names></author> <title>Epidemiology of lung cancer: a general update</title> <source>Eur Respir Rev</source> <year>2002</year> <volume>12</volume> <fpage>112</fpage> - <lpage>121</lpage>
<author><surname>Baker</surname> <given-names>GL</given-names></author> <author><surname>Barnes</surname> <given-names>HJ</given-names></author> <title>Superior vena cava syndrome: etiology, diagnosis, and treatment</title> <source>Am J Crit Care</source> <year>1992</year> <volume>1</volume> <fpage>54</fpage> - <lpage>64</lpage>
<author><surname>Hyde</surname> <given-names>L</given-names></author> <author><surname>Hyde</surname> <given-names>CI</given-names></author> <title>Clinical manifestations of lung cancer</title> <source>Chest</source> <year>1974</year> <volume>65</volume> <fpage>299</fpage> - <lpage>306</lpage>
<author><surname>Naschitz</surname> <given-names>JE</given-names></author> <author><surname>Yeshurun</surname> <given-names>D</given-names></author> <author><surname>Eldar</surname> <given-names>S</given-names></author> <author><surname>Lev</surname> <given-names>LM</given-names></author> <title>Diagnosis of cancer associated vascular disorders</title> <source>Cancer</source> <year>1996</year> <volume>77</volume> <fpage>1759</fpage> - <lpage>1767</lpage>
<author><surname>Dyet</surname> <given-names>JF</given-names></author> <author><surname>Nicholson</surname> <given-names>AA</given-names></author> <author><surname>Cook</surname> <given-names>AM</given-names></author> <title>The use of the wallstent endovascular prosthesis in the treatment of malignant obstruction of the superior vena cava</title> <source>Clin Radiol</source> <year>1993</year> <volume>48</volume> <fpage>381</fpage> - <lpage>385</lpage>
<author><surname>Takeda</surname> <given-names>T</given-names></author> <author><surname>Saiton</surname> <given-names>M</given-names></author> <author><surname>Takeda</surname> <given-names>S</given-names></author> <title>Superior vena cava syndrome caused by an intravascular thrombosis due to underlying prostate carcinoma</title> <source>Intern Med</source> <year>2008</year> <volume>47</volume> <fpage>2007</fpage> - <lpage>2010</lpage>
<author><surname>Sack</surname> <given-names>GH</given-names></author> <author><surname>Jr Levin</surname> <given-names>J</given-names></author> <author><surname>Bell</surname> <given-names>WR</given-names></author> <title>Trousseau"s syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features</title> <source>Medicine</source> <year>1977</year> <volume>56</volume> <fpage>1</fpage> - <lpage>37</lpage>
<author><surname>Lin</surname> <given-names>J</given-names></author> <author><surname>Zhou</surname> <given-names>KR</given-names></author> <author><surname>Chen</surname> <given-names>ZW</given-names></author> <author><surname>Wang</surname> <given-names>JH</given-names></author> <author><surname>Yan</surname> <given-names>ZP</given-names></author> <author><surname>Wang</surname> <given-names>YX</given-names></author> <title>Vena cava 3D contrast-enhanced MR venography: a pictorial review</title> <source>Cardiovasc Intervent Radiol</source> <year>2005</year> <volume>28</volume> <fpage>795</fpage> - <lpage>805</lpage>
<author><surname>Tanigawa</surname> <given-names>N</given-names></author> <author><surname>Sawada</surname> <given-names>S</given-names></author> <author><surname>Mishima</surname> <given-names>K</given-names></author> <title>Clinical outcome of stenting in superior vena cava syndrome associated with malignant tumors: comparison with conventional treatment</title> <source>Acta Radiol</source> <year>1998</year> <volume>39</volume> <fpage>669</fpage> - <lpage>674</lpage>
<author><surname>Thony</surname> <given-names>F</given-names></author> <author><surname>Moro</surname> <given-names>D</given-names></author> <author><surname>Witmeyer</surname> <given-names>P</given-names></author> <title>Endovascular treatment of superior vena cava obstruction in patients with malignancies</title> <source>Eur Radiol</source> <year>1999</year> <volume>9</volume> <fpage>965</fpage> - <lpage>971</lpage>
<author><surname>Smayra</surname> <given-names>T</given-names></author> <author><surname>Otal</surname> <given-names>P</given-names></author> <author><surname>Chabbert</surname> <given-names>V</given-names></author> <author><surname>Chemla</surname> <given-names>P</given-names></author> <author><surname>Romero</surname> <given-names>M</given-names></author> <author><surname>Joffre</surname> <given-names>F</given-names></author> <author><surname>Rousseau</surname> <given-names>H</given-names></author> <title>Long-term results of endovascular stent placement in the superior caval venous system</title> <source>Cardiovasc Intervent Radiol</source> <year>2001</year> <volume>24</volume> <fpage>388</fpage> - <lpage>394</lpage>
<author><surname>Gauden</surname> <given-names>SJ</given-names></author> <title>Superior vena cava syndrome induced by bronchogenic carcinoma: is this an oncological emergency</title>? <source>Australas Radiol</source> <year>1993</year> <volume>37</volume> <fpage>363</fpage> - <lpage>366</lpage>
<author><surname>Boardman</surname> <given-names>P</given-names></author> <author><surname>Ettles</surname> <given-names>DF</given-names></author> <title>Cardiac tamponade: a rare complication of attempted stenting in malignant superior vena caval obstruction</title> <source>Clin Radiol</source> <year>2000</year> <volume>55</volume> <fpage>645</fpage> - <lpage>647</lpage>
<author><surname>Irving</surname> <given-names>JD</given-names></author> <author><surname>Dondelinger</surname> <given-names>RF</given-names></author> <author><surname>Reidy</surname> <given-names>JF</given-names></author> <author><surname>Schild</surname> <given-names>H</given-names></author> <author><surname>Dick</surname> <given-names>R</given-names></author> <author><surname>Adam</surname> <given-names>A</given-names></author> <author><surname>Maynar</surname> <given-names>M</given-names></author> <author><surname>Zollikofer</surname> <given-names>CL</given-names></author> <title>Gianturco self-expanding stents: clinical experience in the vena cava and large veins</title> <source>Cardiovasc Intervent Radiol</source> <year>1992</year> <volume>15</volume> <fpage>328</fpage> - <lpage>333</lpage>
<author><surname>Geerts</surname> <given-names>WH</given-names></author> <author><surname>Bergqvist</surname> <given-names>D</given-names></author> <author><surname>Pineo</surname> <given-names>GF</given-names></author> <author><surname>Heit</surname> <given-names>JA</given-names></author> <author><surname>Samama</surname> <given-names>CM</given-names></author> <author><surname>Lassen</surname> <given-names>MR</given-names></author> <author><surname>Colwell</surname> <given-names>CW</given-names></author> <title>American College of Chest Physicians Prevention of venous thromboembolism</title>: <source>American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest</source> <year>2008</year> <volume>133</volume> <issue>8 6</issue> <other>Suppl</other> <fpage>381</fpage> - <lpage>453</lpage> - <lpage></lpage>
<author><surname>Logemann</surname> <given-names>J.A</given-names></author>. <source>Evaluation and Treatment of Swallowing Disorders</source> <year>1998</year> <other>Austin, TX</other> <publisher>Pro-ed</publisher>
<author><surname>Miller</surname> <given-names>A.J</given-names></author>. <source>The Neuroscientific Principles of Swallowing and Dysphagia</source> <year>1999</year> <other>San Diego; London</other> <publisher>Singular Publishing Group</publisher>
<author><surname>Miyaoka</surname> <given-names>Y</given-names></author> <author><surname>Ashida</surname> <given-names>I</given-names></author> <author><surname>Kawakami</surname> <given-names>S</given-names></author> <author><surname>Miyaoka</surname> <given-names>S</given-names></author> <author><surname>Igarashi</surname> <given-names>A</given-names></author> <author><surname>Yamada</surname> <given-names>Y</given-names></author> <title>Age-related influences on activity patterns in the suprahyoid muscles during swallowing: preliminary analysis</title> <source>Journal of Sensory Studies</source> <year>2007</year> <volume>22</volume> <fpage>394</fpage> - <lpage>402</lpage>
<author><surname>Miyaoka</surname> <given-names>Y</given-names></author> <author><surname>Ashida</surname> <given-names>I</given-names></author> <author><surname>Kawakami</surname> <given-names>S</given-names></author> <author><surname>Miyaoka</surname> <given-names>S</given-names></author> <title>Differentiation of activity patterns in the suprahyoid muscles during swallowing of umami tasting foods</title> <source>Journal of Sensory Studies</source> <year>2006</year> <volume>21</volume> <fpage>572</fpage> - <lpage>583</lpage>
<author><surname>Miyaoka</surname> <given-names>Y</given-names></author> <author><surname>Ashida</surname> <given-names>I</given-names></author> <author><surname>Inagaki</surname> <given-names>D</given-names></author> <author><surname>Kawakami</surname> <given-names>S</given-names></author> <title>Differentiation of activity patterns in the suprahyoid muscles during swallowing of foods with five taste qualities</title> <source>Journal of Sensory Studies</source> <year>2005</year> <volume>20</volume> <fpage>473</fpage> - <lpage>483</lpage>
<author><surname>Ashida</surname> <given-names>I</given-names></author> <author><surname>Iwamori</surname> <given-names>H</given-names></author> <author><surname>Kawakami</surname> <given-names>S</given-names></author> <author><surname>Miyaoka</surname> <given-names>Y</given-names></author> <author><surname>Murayama</surname> <given-names>A</given-names></author> <title>Analysis of physiological parameters of masseter muscle activity during chewing of agars in healthy young males</title> <source>Journal of Texture Studies</source> <year>2007</year> <volume>38</volume> <fpage>87</fpage> - <lpage>99</lpage>
<author><surname>Taniguchi</surname> <given-names>H</given-names></author> <author><surname>Tsukada</surname> <given-names>T</given-names></author> <author><surname>Ootaki</surname> <given-names>S</given-names></author> <author><surname>Yamada</surname> <given-names>Y</given-names></author> <author><surname>Inoue</surname> <given-names>M</given-names></author> <title>Correspondence between food consistency and suprahyoid muscle activity, tongue pressure, and bolus transit times during the oropharyngeal phase of swallowing</title> <source>Journal of Applied Physiology</source> <year>2008</year> <volume>105</volume> <fpage>791</fpage> - <lpage>799</lpage>
<author><surname>Bourne</surname> <given-names>M.C</given-names></author>. <source>Food Texture and Viscosity &#8211; Concept and Measurement &#8211; Food Science and Technology</source> <year>2002</year> <other>New York</other> <publisher>Academic Press</publisher>
<author><surname>Ashida</surname> <given-names>I</given-names></author> <author><surname>Miyaoka</surname> <given-names>S</given-names></author> <author><surname>Miyaoka</surname> <given-names>Y</given-names></author> <title>Comparison of video-recorded laryngeal movements during swallowing by normal young men with piezoelectric sensor and electromyographic signals</title> <source>Journal of Medical Engineering &amp; Technology</source> <year>2009</year> <volume>33</volume> <fpage>496</fpage> - <lpage>501</lpage>
<author><surname>Miyaoka</surname> <given-names>Y</given-names></author> <author><surname>Haishima</surname> <given-names>K</given-names></author> <author><surname>Takagi</surname> <given-names>M</given-names></author> <author><surname>Haishima</surname> <given-names>H</given-names></author> <author><surname>Asari</surname> <given-names>J</given-names></author> <author><surname>Yamada</surname> <given-names>Y</given-names></author> <title>Influences of thermal and gustatory characteristics on sensory and motor aspects of swallowing</title> <source>Dysphagia</source> <year>2006</year> <volume>21</volume> <fpage>38</fpage> - <lpage>48</lpage>
<author><surname>Bisch</surname> <given-names>E.M</given-names></author>. <author><surname>Logemann</surname> <given-names>J.A</given-names></author>. <author><surname>Rademaker</surname> <given-names>A.W</given-names></author>. <author><surname>Kahrilas</surname> <given-names>P.J</given-names></author>. <author><surname>Lazarus</surname> <given-names>C.L</given-names></author>. <title>Pharyngeal effects of bolus volume, viscosity, and temperature in patients with dysphagia resulting from neurologic impairment and in normal subjects</title> <source>Journal of Speech and Hearing Research</source> <year>1994</year> <volume>37</volume> <fpage>1041</fpage> - <lpage>1059</lpage>
<author><surname>Dantas</surname> <given-names>R.O</given-names></author>. <author><surname>Dodds</surname> <given-names>W.J</given-names></author>. <author><surname>Massey</surname> <given-names>B.T</given-names></author>. <author><surname>Kern</surname> <given-names>M.K</given-names></author>. <title>The effect of high-vs low-density barium preparations on the quantitative features of swallowing</title> <source>AJR American Journal of Roentgenology</source> <year>1989</year> <volume>153</volume> <fpage>1191</fpage> - <lpage>1195</lpage>
<author><surname>Dantas</surname> <given-names>R.O</given-names></author>. <author><surname>Kern</surname> <given-names>M.K</given-names></author>. <author><surname>Massey</surname> <given-names>B.T</given-names></author>. <author><surname>Dodds</surname> <given-names>W.J</given-names></author>. <author><surname>Kahrilas</surname> <given-names>P.J</given-names></author>. <author><surname>Brasseur</surname> <given-names>J.G</given-names></author>. <author><surname>Cook</surname> <given-names>I.J</given-names></author>. <author><surname>Lang</surname> <given-names>I.M</given-names></author>. <title>Effect of swallowed bolus variables on oral and pharyngeal phases of swallowing</title> <source>American Journal of Physiology</source> <year>1990</year> <volume>258</volume> <fpage>G675</fpage> - <lpage>681</lpage>
<author><surname>Lazarus</surname> <given-names>C.L</given-names></author>. <author><surname>Logemann</surname> <given-names>J.A</given-names></author>. <author><surname>Rademaker</surname> <given-names>A.W</given-names></author>. <author><surname>Kahrilas</surname> <given-names>P.J</given-names></author>. <author><surname>Pajak</surname> <given-names>T</given-names></author> <author><surname>Lazar</surname> <given-names>R</given-names></author> <author><surname>Halper</surname> <given-names>A</given-names></author> <title>Effects of bolus volume, viscosity, and repeated swallows in nonstroke subjects and stroke patients</title> <source>Archives of Physical Medicine and Rehabilitation</source> <year>1993</year> <volume>74</volume> <fpage>1066</fpage> - <lpage>1070</lpage>
<author><surname>Dantas</surname> <given-names>R.O</given-names></author>. <author><surname>Dodds</surname> <given-names>W.J</given-names></author>. <title>Effect of bolus volume and consistency on swallow-induced submental and infrahyoid electromyographic activity</title> <source>Brazilian Journal of Medical and Biological Research</source> <year>1990</year> <volume>23</volume> <fpage>37</fpage> - <lpage>44</lpage>
Department of Health <year>2007</year> <title>HPV vaccine recommended for NHS routine immunisation programme Available at: accessed 14th</title> December 2010
Department of Health <year>2010</year> <source>HPV vaccination &#8211; who can use it? NHS Choices. Available at</source> accessed 14th December 2010
International Agency <title>for Research on Cancer (IARC) Monographs on the Evaluation of Carcinogenic</title> <source>Risks to Humans No. 63. Human Papillomaviruses IARC Lyon</source> <year>1995</year>
<author><surname>Mays</surname> <given-names>RM</given-names></author> <author><surname>Sturm</surname> <given-names>LA</given-names></author> <author><surname>Zimet</surname> <given-names>GD</given-names></author> <title>Parental perspectives on vaccinating children against sexually transmitted infections</title> <source>Soc Sci Med</source> <year>2004</year> <volume>58</volume> <fpage>1405</fpage> - <lpage>13</lpage>
<author><surname>Hilton</surname> <given-names>S</given-names></author> <author><surname>Hunt</surname> <given-names>K</given-names></author> <author><surname>Petticrew</surname> <given-names>M</given-names></author> <title>Gaps in parental understandings and experiences of vaccine-preventable diseases: a qualitative study</title> <source>Child: Care, Health and Development</source> <year>2006</year> <volume>33</volume> <issue>2</issue> <fpage>170</fpage> - <lpage>9</lpage>
<author><surname>Brabin</surname> <given-names>L</given-names></author> <author><surname>Roberts</surname> <given-names>SA</given-names></author> <author><surname>Farzaneh</surname> <given-names>F</given-names></author> <author><surname>Kitchener</surname> <given-names>HC</given-names></author> <title>Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes</title> <source>Vaccine</source> <year>2006</year> <volume>24</volume> <fpage>3087</fpage> - <lpage>94</lpage>
<author><surname>Waller</surname> <given-names>J</given-names></author> <author><surname>Marlow</surname> <given-names>L</given-names></author> <author><surname>Wardle</surname> <given-names>J</given-names></author> <title>Mothers" attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study</title> <source>Cancer Epidemiology Biomarkers Prev</source> <year>2006</year> <volume>15</volume> <issue>7</issue> <fpage>1257</fpage> - <lpage>61</lpage>
<author><surname>Raffle</surname> <given-names>AE</given-names></author> <title>Challenges of implementing human papillomavirus (HPV) vaccination policy</title> <source>BMJ</source> <year>2007</year> <volume>335</volume> <fpage>375</fpage> - <lpage>7</lpage>
<author><surname>Cooper Robbins</surname> <given-names>SC</given-names></author> <author><surname>Bernard</surname> <given-names>D</given-names></author> <author><surname>McCaffery</surname> <given-names>K</given-names></author> <author><surname>Brotherton</surname> <given-names>J</given-names></author> <author><surname>Garland</surname> <given-names>S</given-names></author> <author><surname>Skinner</surname> <given-names>SR</given-names></author> &#<title>8216;Is cancer contagious?&#8217;: Australian adolescent girls and their parents: making the most of limited information about HPV and HPV vaccination</title> <source>Vaccine</source> <year>2010</year> <volume>28</volume> <issue>19</issue> <fpage>3398</fpage> - <lpage>408</lpage>
<author><surname>Williams</surname> <given-names>K</given-names></author> <author><surname>Forster</surname> <given-names>A</given-names></author> <author><surname>Marlow</surname> <given-names>L</given-names></author> <author><surname>Waller</surname> <given-names>J</given-names></author> <title>Adolescents attitudes towards human papillomavirus vaccination: an exploratory qualitative study</title> <source>J Fam Plann</source> <year>2011</year> <volume>37</volume> <fpage>22</fpage> - <lpage>5</lpage>
<author><surname>Klug</surname> <given-names>SJ</given-names></author> <author><surname>Hukelmann</surname> <given-names>M</given-names></author> <author><surname>Blettner</surname> <given-names>M</given-names></author> <title>Knowledge about infection with human papillomavirus: a systematic review</title> <source>Preventive Medicine</source> <year>2008</year> <volume>46</volume> <fpage>87</fpage> - <lpage>98</lpage>
<author><surname>Kollar</surname> <given-names>LM</given-names></author> <author><surname>Kahn</surname> <given-names>JA</given-names></author> <title>Education about human papillomavirus and human papillomavirus vaccines in adolescents</title> <source>Adolescent and Pediatric Gynecology</source> <year>2008</year> <volume>20</volume> <issue>5</issue> <fpage>479</fpage> - <lpage>83</lpage>
<author><surname>Franco</surname> <given-names>EL</given-names></author> <author><surname>Cuzick</surname> <given-names>J</given-names></author> <author><surname>Hildesheim</surname> <given-names>A</given-names></author> <title>Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination</title>. <source>Vaccine</source> <year>2006</year> <volume>171-177</volume>
<author><surname>Adams</surname> <given-names>M</given-names></author> <author><surname>Jasani</surname> <given-names>B</given-names></author> <author><surname>Fiander</surname> <given-names>A</given-names></author> <title>Human papillomavirus (HPV) prophylactic vaccination: challenges of public health and implications for screening</title> <source>Vaccine</source> <year>2007</year> <volume>25</volume> <fpage>3007</fpage> - <lpage>13</lpage>
Department of Health <year>2010</year> <source>NHS Cancer Screening Programmes. Cervical Screening Programme. Available at: accessed 14th</source> December 2010
<author><surname>HPV Core</surname> <given-names>Messages</given-names></author> <title>Group. Development and evaluation of a set of core Human Papillomavirus (HPV) messages to promote informed choice for both tests and vaccines for use in primary care and broader settings in the UKPoster presentation</title> <source>National Cancer Research Institute Conference, October</source> <year>2009</year>, Birmingham. Available at: accessed 14th December 2010
<author><surname>Glaser</surname> <given-names>B</given-names></author> <author><surname>Strauss</surname> <given-names>A</given-names></author> <source>The Discovery of Grounded Theory</source> <other>New York</other> <publisher>Aldine Publishing</publisher> <year>1967</year>
<author><surname>Green</surname> <given-names>J</given-names></author> <author><surname>Thorogood</surname> <given-names>N</given-names></author> <source>Qualitative Methods for Health Research</source> <other>London</other> <publisher>Sage</publisher> <year>2004</year>
<source>Atlas.ti The Knowledge Workbench</source> <year>1993</year> <other>Berlin, Germany</other> <publisher>Atlas.ti Version</publisher> <fpage>5</fpage> - <lpage>6</lpage> - <lpage>3</lpage>
<author><surname>Nathan</surname> <given-names>DM</given-names></author> <author><surname>Buse</surname> <given-names>JB</given-names></author> <author><surname>Davidson</surname> <given-names>MB</given-names></author> <title>Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes</title> <source>Diabetes Care</source> <year>2009</year> <volume>32</volume> <fpage>193</fpage> - <lpage>203</lpage>
<author><surname>Akalin</surname> <given-names>S</given-names></author> <author><surname>Berntorp</surname> <given-names>K</given-names></author> <author><surname>Ceriello</surname> <given-names>A</given-names></author> <title>Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control</title> <source>Int J Clin Pract</source> <year>2009</year> <volume>63</volume> <fpage>1421</fpage> - <lpage>1425</lpage>
<author><surname>Albarrak</surname> <given-names>AI</given-names></author> <author><surname>Luzio</surname> <given-names>SD</given-names></author> <author><surname>Chassin</surname> <given-names>LJ</given-names></author> <author><surname>Playle</surname> <given-names>RA</given-names></author> <author><surname>Owens</surname> <given-names>DR</given-names></author> <author><surname>Hovorka</surname> <given-names>R</given-names></author> <title>Associations of glucose control with insulin sensitivity and pancreatic beta-cell responsiveness in newly presenting type 2 diabetes</title> <source>J Clin Endocrinol Metab</source> <year>2002</year> <volume>87</volume> <fpage>198</fpage> - <lpage>203</lpage>
<author><surname>Heinemann</surname> <given-names>L</given-names></author> <author><surname>Chantelau</surname> <given-names>EA</given-names></author> <author><surname>Starke</surname> <given-names>AA</given-names></author> <title>Pharmacokinetics and pharmacodynamics of subcutaneously administered U40 and U100 formulations of regular human insulin</title> <source>Diabete Metab</source> <year>1992</year> <volume>18</volume> <fpage>21</fpage> - <lpage>24</lpage>
<author><surname>Becker</surname> <given-names>RH</given-names></author> <title>Insulin glulisine complementing basal insulins: a review of structure and activity</title> <source>Diabetes Technol Ther</source> <year>2007</year> <volume>9</volume> <fpage>109</fpage> - <lpage>121</lpage>
<author><surname>Becker</surname> <given-names>RH</given-names></author> <author><surname>Frick</surname> <given-names>AD</given-names></author> <title>Clinical pharmacokinetics and pharmacodynamics of insulin glulisine</title> <source>Clin Pharmacokinet</source> <year>2008</year> <volume>47</volume> <fpage>7</fpage> - <lpage>20</lpage>
<author><surname>Becker</surname> <given-names>RH</given-names></author> <author><surname>Frick</surname> <given-names>AD</given-names></author> <author><surname>Burger</surname> <given-names>F</given-names></author> <author><surname>Potgieter</surname> <given-names>JH</given-names></author> <author><surname>Scholtz</surname> <given-names>H</given-names></author> <title>Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects</title> <source>Exp Clin Endocrinol Diabetes</source> <year>2005</year> <volume>113</volume> <fpage>435</fpage> - <lpage>443</lpage>
<author><surname>Heise</surname> <given-names>T</given-names></author> <author><surname>Nosek</surname> <given-names>L</given-names></author> <author><surname>Spitzer</surname> <given-names>H</given-names></author> <title>Insulin glulisine: a faster onset of action compared with insulin lispro</title> <source>Diabetes Obes Metab</source> <year>2007</year> <volume>9</volume> <fpage>746</fpage> - <lpage>753</lpage>
<author><surname>Luzio</surname> <given-names>S</given-names></author> <author><surname>Peter</surname> <given-names>R</given-names></author> <author><surname>Dunseath</surname> <given-names>GJ</given-names></author> <author><surname>Mustafa</surname> <given-names>L</given-names></author> <author><surname>Owens</surname> <given-names>DR</given-names></author> <title>A comparison of preprandial insulin glulisine versus insulin lispro in people with type 2 diabetes over a 12-h period</title> <source>Diabetes Res Clin Pract</source> <year>2008</year> <volume>79</volume> <fpage>269</fpage> - <lpage>275</lpage>
<author><surname>Becker</surname> <given-names>RH</given-names></author> <author><surname>Frick</surname> <given-names>AD</given-names></author> <author><surname>Burger</surname> <given-names>F</given-names></author> <author><surname>Scholtz</surname> <given-names>H</given-names></author> <author><surname>Potgieter</surname> <given-names>JH</given-names></author> <title>A comparison of the steady-state pharmacokinetics and pharmacodynamics of a novel rapid-acting insulin analog, insulin glulisine, and regular human insulin in healthy volunteers using the euglycemic clamp technique</title> <source>Exp Clin Endocrinol Diabetes</source> <year>2005</year> <volume>113</volume> <fpage>292</fpage> - <lpage>297</lpage>
<author><surname>Becker</surname> <given-names>RH</given-names></author> <author><surname>Frick</surname> <given-names>AD</given-names></author> <author><surname>Nosek</surname> <given-names>L</given-names></author> <author><surname>Heinemann</surname> <given-names>L</given-names></author> <author><surname>Rave</surname> <given-names>K</given-names></author> <title>Dose-response relationship of insulin glulisine in subjects with type 1 diabetes</title> <source>Diabetes Care</source> <year>2007</year> <volume>30</volume> <fpage>2506</fpage> - <lpage>2507</lpage>
<author><surname>Danne</surname> <given-names>T</given-names></author> <author><surname>Becker</surname> <given-names>RH</given-names></author> <author><surname>Heise</surname> <given-names>T</given-names></author> <author><surname>Bittner</surname> <given-names>C</given-names></author> <author><surname>Frick</surname> <given-names>AD</given-names></author> <author><surname>Rave</surname> <given-names>K</given-names></author> <title>Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes</title> <source>Diabetes Care</source> <year>2005</year> <volume>28</volume> <fpage>2100</fpage> - <lpage>2105</lpage>
<author><surname>Arnolds</surname> <given-names>S</given-names></author> <author><surname>Rave</surname> <given-names>K</given-names></author> <author><surname>Hovelmann</surname> <given-names>U</given-names></author> <author><surname>Fischer</surname> <given-names>A</given-names></author> <author><surname>Sert-Langeron</surname> <given-names>C</given-names></author> <author><surname>Heise</surname> <given-names>T</given-names></author> <title>Insulin glulisine has a faster onset of action compared with insulin aspart in healthy volunteers</title> <source>Exp Clin Endocrinol Diabetes</source> <year>2010</year> <volume>118</volume> <fpage>662</fpage> - <lpage>664</lpage>
<author><surname>Porcellati</surname> <given-names>F</given-names></author> <author><surname>Rossetti</surname> <given-names>P</given-names></author> <author><surname>Busciantella</surname> <given-names>NR</given-names></author> <title>Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study</title> <source>Diabetes Care</source> <year>2007</year> <volume>30</volume> <fpage>2447</fpage> - <lpage>2452</lpage>
<author><surname>Chow</surname> <given-names>SC</given-names></author> <author><surname>Liu</surname> <given-names>JP</given-names></author> <source>Design and Analysis of Bioavailability and Bioequivalence Studies</source> <year>2000</year> <issue>2nd edn</issue> <other>New York</other> <publisher>Marcel Dekker Revised and Expanded</publisher>
<author><surname>Sluzky</surname> <given-names>V</given-names></author> <author><surname>Tamada</surname> <given-names>JA</given-names></author> <author><surname>Klibanov</surname> <given-names>AM</given-names></author> <author><surname>Langer</surname> <given-names>R</given-names></author> <title>Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces</title> <source>Proc Natl Acad Sci U S A</source> <year>1991</year> <volume>88</volume> <fpage>9377</fpage> - <lpage>9381</lpage>
<author><surname>Bakaysa</surname> <given-names>DL</given-names></author> <author><surname>Radziuk</surname> <given-names>J</given-names></author> <author><surname>Havel</surname> <given-names>HA</given-names></author> <title>Physicochemical basis for the rapid time-action of LysB28ProB29-insulin: dissociation of a protein&#8211;ligand complex</title> <source>Protein Sci</source> <year>1996</year> <volume>5</volume> <fpage>2521</fpage> - <lpage>2531</lpage>
<author><surname>Bhatnagar</surname> <given-names>S</given-names></author> <author><surname>Srivastava</surname> <given-names>D</given-names></author> <author><surname>Jayadev</surname> <given-names>MS</given-names></author> <author><surname>Dubey</surname> <given-names>AK</given-names></author> <title>Molecular variants and derivatives of insulin for improved glycemic control in diabetes</title> <source>Prog Biophys Mol Biol</source> <year>2006</year> <volume>91</volume> <fpage>199</fpage> - <lpage>228</lpage>
<author><surname>Vora</surname> <given-names>JP</given-names></author> <author><surname>Burch</surname> <given-names>A</given-names></author> <author><surname>Peters</surname> <given-names>JR</given-names></author> <author><surname>Owens</surname> <given-names>DR</given-names></author> <title>Absorption of radiolabelled soluble insulin in type 1 (insulin-dependent) diabetes: influence of subcutaneous blood flow and anthropometry</title> <source>Diabet Med</source> <year>1993</year> <volume>10</volume> <fpage>736</fpage> - <lpage>743</lpage>
<author><surname>Vora</surname> <given-names>JP</given-names></author> <author><surname>Burch</surname> <given-names>A</given-names></author> <author><surname>Peters</surname> <given-names>JR</given-names></author> <author><surname>Owens</surname> <given-names>DR</given-names></author> <title>Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry</title> <source>Diabetes Care</source> <year>1992</year> <volume>15</volume> <fpage>1484</fpage> - <lpage>1493</lpage>
<author><surname>Clauson</surname> <given-names>PG</given-names></author> <author><surname>Linde</surname> <given-names>B</given-names></author> <title>Absorption of rapid-acting insulin in obese and nonobese NIDDM patients</title> <source>Diabetes Care</source> <year>1995</year> <volume>18</volume> <fpage>986</fpage> - <lpage>991</lpage>
<author><surname>ter Braak</surname> <given-names>EW</given-names></author> <author><surname>Woodworth</surname> <given-names>JR</given-names></author> <author><surname>Bianchi</surname> <given-names>R</given-names></author> <title>Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin</title> <source>Diabetes Care</source> <year>1996</year> <volume>19</volume> <fpage>1437</fpage> - <lpage>1440</lpage>
<author><surname>Bergenstal</surname> <given-names>RM</given-names></author> <author><surname>Johnson</surname> <given-names>M</given-names></author> <author><surname>Powers</surname> <given-names>MA</given-names></author> <title>Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine</title> <source>Diabetes Care</source> <year>2008</year> <volume>31</volume> <fpage>1305</fpage> - <lpage>1310</lpage>
<author><surname>Parwani</surname> <given-names>AV</given-names></author> <author><surname>Kronz</surname> <given-names>JD</given-names></author> <author><surname>Genega</surname> <given-names>EM</given-names></author> <author><surname>Gaudin</surname> <given-names>P</given-names></author> <author><surname>Chang</surname> <given-names>S</given-names></author> <author><surname>Epstein</surname> <given-names>JI</given-names></author> <title>Prostate carcinoma with squamous differentiation: an analysis of 33 cases</title> <source>Am J Surg Pathol</source> <year>2004</year> <volume>28</volume> <issue>5</issue> <fpage>651</fpage> - <lpage>7</lpage>
<author><surname>Nabi</surname> <given-names>G</given-names></author> <author><surname>Ansari</surname> <given-names>MS</given-names></author> <author><surname>Singh</surname> <given-names>I</given-names></author> <author><surname>Sharma</surname> <given-names>MC</given-names></author> <author><surname>Dogra</surname> <given-names>PN</given-names></author> <title>Primary squamous cell carcinoma of the prostate: a rare clinicopathological entity. Report of 2 cases and review of literature</title> <source>Urol Int</source> <year>2001</year> <volume>66</volume> <issue>4</issue> <fpage>216</fpage> - <lpage>9</lpage>
<author><surname>Mohan</surname> <given-names>H</given-names></author> <author><surname>Bal</surname> <given-names>A</given-names></author> <author><surname>Punia</surname> <given-names>RP</given-names></author> <author><surname>Bawa</surname> <given-names>AS</given-names></author> <title>Squamous cell carcinoma of the prostate</title> <source>Int J Urol</source> <year>2003</year> <volume>10</volume> <issue>2</issue> <fpage>114</fpage> - <lpage>6</lpage>
<author><surname>Rahmanou</surname> <given-names>F</given-names></author> <author><surname>Koo</surname> <given-names>J</given-names></author> <author><surname>Marinbakh</surname> <given-names>AY</given-names></author> <author><surname>Solliday</surname> <given-names>MP</given-names></author> <author><surname>Grob</surname> <given-names>BM</given-names></author> <author><surname>Chin</surname> <given-names>NW</given-names></author> <title>Squamous cell carcinoma at the prostatectomy site: squamous differentiation of recurrent prostate carcinoma</title> <source>Urology</source> <year>1999</year> <volume>54</volume> <issue>4</issue> <fpage>744</fpage>
<author><surname>Okada</surname> <given-names>E</given-names></author> <author><surname>Kamizaki</surname> <given-names>H</given-names></author> <title>Primary squamous cell carcinoma of the prostate</title> <source>Int J Urol</source> <year>2000</year> <volume>7</volume> <issue>9</issue> <fpage>347</fpage> - <lpage>50</lpage>
<author><surname>Sarma</surname> <given-names>DP</given-names></author> <author><surname>Weilbaecher</surname> <given-names>TG</given-names></author> <author><surname>Moon</surname> <given-names>TD</given-names></author> <title>Squamous cell carcinoma of prostate</title> <source>Urology</source> <year>1991</year> <volume>37</volume> <issue>3</issue> <fpage>260</fpage> - <lpage>2</lpage>
<author><surname>Li</surname> <given-names>W</given-names></author> <author><surname>Cagle</surname> <given-names>PT</given-names></author> <author><surname>Botero</surname> <given-names>RC</given-names></author> <author><surname>Liang</surname> <given-names>JJ</given-names></author> <author><surname>Zhang</surname> <given-names>Z</given-names></author> <author><surname>Tan</surname> <given-names>D</given-names></author> <title>Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma</title> <source>J Exp Clin Cancer Res</source> <year>2008</year> <volume>27</volume> <fpage>2</fpage>
<author><surname>Devaney</surname> <given-names>DM</given-names></author> <author><surname>Dorman</surname> <given-names>A</given-names></author> <author><surname>Leader</surname> <given-names>M</given-names></author> <title>Adenosquamous carcinoma of the prostate: a case report</title> <source>Hum Pathol</source> <year>1991</year> <volume>22</volume> <issue>10</issue> <fpage>1046</fpage> - <lpage>50</lpage>
<author><surname>Bassler</surname> <given-names>TJ</given-names></author> <author><surname>Jr Orozco</surname> <given-names>R</given-names></author> <author><surname>Bassler</surname> <given-names>IC</given-names></author> <author><surname>Boyle</surname> <given-names>LM</given-names></author> <author><surname>Bormes</surname> <given-names>T</given-names></author> <title>Adenosquamous carcinoma of the prostate: case report with DNA analysis, immunohistochemistry, and literature review</title> <source>Urology</source> <year>1999</year> <volume>53</volume> <issue>4</issue> <fpage>832</fpage> - <lpage>4</lpage>
<author><surname>Kanthan</surname> <given-names>R</given-names></author> <author><surname>Torkian</surname> <given-names>B</given-names></author> <title>Squamous cell carcinoma of the prostate. A report of 6 cases</title> <source>Urol Int</source> <year>2004</year> <volume>72</volume> <issue>1</issue> <fpage>28</fpage> - <lpage>31</lpage>
<author><surname>Miller</surname> <given-names>VA</given-names></author> <author><surname>Reuter</surname> <given-names>V</given-names></author> <author><surname>Scher</surname> <given-names>HI</given-names></author> <title>Primary squamous cell carcinoma of the prostate after radiation seed implantation for adenocarcinoma</title> <source>Urology</source> <year>1995</year> <volume>46</volume> <issue>1</issue> <fpage>111</fpage> - <lpage>3</lpage>
<author><surname>Wernert</surname> <given-names>N</given-names></author> <author><surname>Goebbels</surname> <given-names>R</given-names></author> <author><surname>Bonkhoff</surname> <given-names>H</given-names></author> <author><surname>Dhom</surname> <given-names>G</given-names></author> <title>Squamous cell carcinoma of the prostate</title> <source>Histopathology</source> <year>1990</year> <volume>17</volume> <issue>4</issue> <fpage>339</fpage> - <lpage>44</lpage>
<author><surname>Braslis</surname> <given-names>KG</given-names></author> <author><surname>Davi</surname> <given-names>RC</given-names></author> <author><surname>Nelson</surname> <given-names>E</given-names></author> <author><surname>Civantos</surname> <given-names>F</given-names></author> <author><surname>Soloway</surname> <given-names>MS</given-names></author> <title>Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide</title> <source>Urology</source> <year>1995</year> <volume>45</volume> <issue>2</issue> <fpage>329</fpage> - <lpage>3</lpage>
<author><surname>John</surname> <given-names>TT</given-names></author> <author><surname>Bashir</surname> <given-names>J</given-names></author> <author><surname>Burrow</surname> <given-names>CT</given-names></author> <author><surname>Machin</surname> <given-names>DG</given-names></author> <title>Squamous cell carcinoma of the prostate--a case report</title> <source>Int Urol Nephrol</source> <year>2005</year> <volume>37</volume> <issue>2</issue> <fpage>311</fpage> - <lpage>3</lpage>
<author><surname>Little</surname> <given-names>NA</given-names></author> <author><surname>Wiener</surname> <given-names>JS</given-names></author> <author><surname>Walther</surname> <given-names>PJ</given-names></author> <author><surname>Paulson</surname> <given-names>DF</given-names></author> <author><surname>Anderson</surname> <given-names>EE</given-names></author> <title>Squamous cell carcinoma of the prostate: 2 cases of a rare malignancy and review of the literature</title> <source>J Urol</source> <year>1993</year> <volume>149</volume> <issue>1</issue> <fpage>137</fpage> - <lpage>9</lpage>
<author><surname>Uchibayashi</surname> <given-names>T</given-names></author> <author><surname>Hisazumi</surname> <given-names>H</given-names></author> <author><surname>Hasegawa</surname> <given-names>M</given-names></author> <title>Squamous cell carcinoma of the prostate</title> <source>Scand J Urol Nephrol</source> <year>1997</year> <volume>31</volume> <issue>2</issue> <fpage>223</fpage> - <lpage>4</lpage>
<author><surname>Di Pietro</surname> <given-names>C</given-names></author> <author><surname>Celia</surname> <given-names>A</given-names></author> <author><surname>De Stefani</surname> <given-names>S</given-names></author> <author><surname>Saredi</surname> <given-names>G</given-names></author> <author><surname>Bianchi</surname> <given-names>G</given-names></author> <title>Squamous cell carcinoma of the prostate</title> <source>Arch Ital Urol Androl</source> <year>2006</year> <volume>78</volume> <issue>2</issue> <fpage>75</fpage> - <lpage>6</lpage>
